好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2010 Annual Meeting | Poster Session 03

Wednesday 04/14/10
07:30 AM - 12:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Sleep, Aging and Dementia, Anterior Horn, Behavioral Neurology, Child Neurology/Developmental Neurobiology, Epilepsy, Infections/AIDS/Prion Disease, MS and Related Diseases, Muscle Disease/Neuromuscular Junction, Neurogenetics and Gene Therapy, Peripheral Nerve
No CME available
Event Timeline
07:00 AM - 08:30 AM Break
07:30 AM - 12:00 PM Abstract 001 - Neuropathological Studies of Patients with Non-Herpetic Acute Limbic Encephalitis
07:30 AM - 12:00 PM Abstract 002 - Surveillance for Progressive Multifocal Leukoencephalopathy: Possible Approaches
07:30 AM - 12:00 PM Abstract 003 - The Prevalence of Human Polyomavirus DNA in Cerebrospinal Fluid of Patients with Varied Neurological Diseases
07:30 AM - 12:00 PM Abstract 004 - Clinical Manifestations in Two Spanish Families with Creutzfeldt-Jakob Disease
07:30 AM - 12:00 PM Abstract 005 - Pruritus in Creutzfeldt-Jakob Disease
07:30 AM - 12:00 PM Abstract 006 - How To Interpret a Blood Contaminated Traumatic Spinal Tap?
07:30 AM - 12:00 PM Abstract 007 - A Simple Method To Reduce Infection of Ventriculoperitoneal Shunts
07:30 AM - 12:00 PM Abstract 008 - Therapeutic Challenge of Neurotuberculosis: An Observational Case Study
07:30 AM - 12:00 PM Abstract 009 - Development of CNS Complications after Initiation of Antituberculosis Treatment
07:30 AM - 12:00 PM Abstract 010 - Tuberculosis, an Uncommon Cause of Cerebral Venous Thrombosis in Children
07:30 AM - 12:00 PM Abstract 011 - Bartonella Cat Scratch Disease Presenting as Neuroretinitis and Headache without Lymphadenopathy
07:30 AM - 12:00 PM Abstract 012 - Meningoencephalitis Caused by Rickettsia Conori
07:30 AM - 12:00 PM Abstract 013 - The Role of Dexamethasone in Cryptococcus gattii Meningitis
07:30 AM - 12:00 PM Abstract 014 - Neurocysticercosis: A Not so Rare Parasitic Infection in Geneva, Switzerland
07:30 AM - 12:00 PM Abstract 015 - Admission Surveillance Cultures for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococci (VRE) in a Neurocritical Care Unit
07:30 AM - 12:00 PM Abstract 016 - Cladophialophora bantiana Cerebral Abscesses in an Immunocompetent Host
07:30 AM - 12:00 PM Abstract 017 - Trends in Outcomes and Hospitalization Costs among Patients with Tetanus in the United States
07:30 AM - 12:00 PM Abstract 018 - Brain MRI in Sporadic Jakob-Creutzfeldt Disease Is Often Misread
07:30 AM - 12:00 PM Abstract 019 - Distinct Patterns of Cerebral Blood Flow in Frontotemporal Lobar Degeneration and Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 020 - The Value of FDG-PET Imaging in the Diagnosis of Atypical/Unclear Dementias: A Retrospective Memory Clinic Study
07:30 AM - 12:00 PM Abstract 021 - Hippocampal Gray Matter Volume Declines at a Faster Rate in Cognitively Normal APOE e4 Carriers
07:30 AM - 12:00 PM Abstract 022 - Mapping Amygdalar Structural Differences in Alzheimer's Patients with 3T MRI
07:30 AM - 12:00 PM Abstract 023 - Mapping Cortical Thickness in Autosomal Dominant Alzheimer's Disease Carriers
07:30 AM - 12:00 PM Abstract 024 - Survey of Protocols for Manual Hippocampal Volumetry: Preparatory Steps for an EADC-ADNI Harmonized Protocol
07:30 AM - 12:00 PM Abstract 025 - Predictive Value of an Index of Cholinergic Damage (ICD) for Cognitive Performance in Alzheimer Disease
07:30 AM - 12:00 PM Abstract 026 - Hypothalamic Atrophy and Decline in Physical Activity Are Associated with Bone Loss in a Study of Non-Demented Aging and Early Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 027 - Seriation of Cortical Atrophy in the Degenerative Dementias
07:30 AM - 12:00 PM Abstract 028 - Brain Cortex Thinning in Motor and Extra-Motor Areas in Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM Abstract 029 - Clinical Features and Natural History in ALS Patients with Upper Motor Neuron Abnormalities on Conventional Brain MRI
07:30 AM - 12:00 PM Abstract 030 - Fibre Tractography of the Corticospinal Tract in Recent Onset Motor Neuron Disease: A Longitudinal Study
07:30 AM - 12:00 PM Abstract 031 - Proton MRS of Thalamus and Basal Ganglia in Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM Abstract 032 - DTI and MRS of the Cervical Spinal Cord in ALS
07:30 AM - 12:00 PM Abstract 033 - The Utilization of 3 Tesla Neuroimaging as a Biomarker for Cognitive Impairment in Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM Abstract 034 - Nuclear Magnetic Resonance (NMR)-Based Metabolomic Analysis of Cerebrospinal Fluid (CSF) in Amyotrophic Lateral Sclerosis (ALS) Patients
07:30 AM - 12:00 PM Abstract 035 - Assessing Motor Neuron Loss in the ALS Rat with Electrical Impedance Myography
07:30 AM - 12:00 PM Abstract 036 - Clinical and MRI Predictors of Long-Term Evolution in Amyotrophic Lateral Sclerosis: A 3.4 Year Follow Up Study
07:30 AM - 12:00 PM Abstract 037 - Degeneration of the Mid Cingulate Cortex in Amyotrophic Lateral Sclerosis Detected In Vivo with MR Spectroscopy
07:30 AM - 12:00 PM Abstract 038 - Upper Motor Neuron and Extramotor White Matter Involvement in Phenotypes of Recent Onset Motor Neuron Disease; a Longitudinal Diffusion Tensor Study Using Voxel-Based Analyses
07:30 AM - 12:00 PM Abstract 039 - Outcome Measures Validation Study for Mesoangioblasts Transplantation in Children Affected by Duchenne Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 040 - The 6-Minute Walk Test in Duchenne Muscular Dystrophy: Longitudinal Observations
07:30 AM - 12:00 PM Abstract 041 - Pulmonary Function Characteristics of Boys with Duchenne and Becker Muscular Dystrophy by Age Groups and Steroid Use: One-Year Data from the CINRG Longitudinal Study Project
07:30 AM - 12:00 PM Abstract 043 - Risk Factors for Fractures in the Muscular Dystrophy Surveillance, Tracking and Research Network Cohort
07:30 AM - 12:00 PM Abstract 044 - Preclinical Safety of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Being Developed To Skip Exon 51 in Duchenne Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 045 - Should All Patients with FSHD Be Screened for Retinal Telangiectasias?
07:30 AM - 12:00 PM Abstract 046 - Muscle Imaging in Oculopharyngeal Muscular Dystrophy
07:30 AM - 12:00 PM Abstract 047 - Are Brain White Matter Changes and Muscle Involvement Related in DM1?
07:30 AM - 12:00 PM Abstract 048 - Brain Morphometry and Psychological Evaluation in Myotonic Dystrophy Type 1 (DM1)
07:30 AM - 12:00 PM Abstract 049 - The Correlation between GPIa C807T SNPs and Young Ischemic Stroke in Shanghai Chinese of Han Population
07:30 AM - 12:00 PM Abstract 050 - Using Latent Semantic Analysis To Measure the Association of KCNN4 and ACTA2 Genes and Ischemic Stroke
07:30 AM - 12:00 PM Abstract 051 - A Novel Heteroplasmic Cytochrome b Mutation in the Mitochondrial DNA Is Associated with MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes)
07:30 AM - 12:00 PM Abstract 052 - Genome-Wide Association Studies of MRI-Defined Brain Infarcts: Meta-Analysis from the CHARGE Consortium
07:30 AM - 12:00 PM Abstract 053 - Evidence for a Heritable Contribution to Death from Ischemic Stroke
07:30 AM - 12:00 PM Abstract 054 - Utility of Measuring Distal Motor Function in the NIHSS: Correlation with Motor Arm Function
07:30 AM - 12:00 PM Abstract 055 - Brain Arteriovenous Malformations: Outcome after Interventional Versus Conservative Management. Prospective Study of 302 Patients
07:30 AM - 12:00 PM Abstract 056 - Non-Convulsive Status Epilepticus after Acute Ischemic Stroke
07:30 AM - 12:00 PM Abstract 057 - Young Women's Stroke Etiology Differs from Young Men: An Analysis of 511 Patients
07:30 AM - 12:00 PM Abstract 058 - Short-Term Stroke Outcomes in the Oldest Old: A Buenos Aires Heath System Study
07:30 AM - 12:00 PM Abstract 059 - The No Smoking Sign: Insular Infarction
07:30 AM - 12:00 PM Abstract 060 - Whole-Brain CT Perfusion (CTP) Using a Novel Volume Helical Shuttle (VHS) Technique on a Conventional 64-Slice CT Scanner: Utility in Routine Stroke Evaluation
07:30 AM - 12:00 PM Abstract 061 - Frequency and Characterization of MR Diffusion Lesions in Acute Spontaneous Intracerebral Hemorrhage
07:30 AM - 12:00 PM Abstract 062 - Detecting Infarcted Tissue with Perfusion-Based Measures on MRI
07:30 AM - 12:00 PM Abstract 063 - Diagnostic and Prognostic Value of Magnetic Resonance Imaging in Spinal Dural Arteriovenous Fistula
07:30 AM - 12:00 PM Abstract 064 - Imaging More with Less: Whole Brain 64-Slice Stroke CT Imaging Using Currently Available Volume Shuttle (VS) and Novel Volume Helical Shuttle (VHS) Brain Perfusion Does Not Increase Radiation Exposure
07:30 AM - 12:00 PM Abstract 065 - How Accurate Is 3D Rotational Angiography in Evaluating Intracranial Stenosis in Patients with Stroke?
07:30 AM - 12:00 PM Abstract 066 - 3D CT Angiography for Detection of Intracranial Aneurysms: Comparison with 3D Rotational Angiography
07:30 AM - 12:00 PM Abstract 067 - Computational Fluid Dynamics of Retrograde Leptomeningeal Collateral Flow in Acute Ischemic Ischemic Stroke: Unique Insight on Essential Hemodynamics
07:30 AM - 12:00 PM Abstract 068 - Volume of Infarction on Diffusion Weighted Imaging Predicts Poor Neurologic Outcome in Children Following an Acute Ischemic Stroke
07:30 AM - 12:00 PM Abstract 069 - A Combined Power M-Mode and Spectrogram TCD Microemboli Signal Criteria for Improving Emboli Detection and Reliability
07:30 AM - 12:00 PM Abstract 070 - Microbleed Detection in Traumatic Brain Injury by 7T MRI
07:30 AM - 12:00 PM Abstract 071 - Yield of Diagnostic Tests in Evaluating Syncopal Episodes in the Emergency Room
07:30 AM - 12:00 PM Abstract 072 - Is Admission and Diagnostic Testing Needed To Evaluate Syncope?
07:30 AM - 12:00 PM Abstract 073 - An Unusual Case of Bilateral Carotid Artery Webs and Stroke
07:30 AM - 12:00 PM Abstract 074 - Comparison of NASCET and ECST Ratio with Absolute Methods of Measurement for Grading Carotid Artery Stenosis with Non Invasive Imaging Modalities
07:30 AM - 12:00 PM Abstract 075 - Transcranial Doppler Ultrasonography (TDU) Is Useful in Guiding Treatment of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage (SAH)
07:30 AM - 12:00 PM Abstract 076 - MRI Diffusion-Weighted Imaging for Predicting Poor Outcome Following Cardiac Arrest
07:30 AM - 12:00 PM Abstract 077 - Distal Hyperintense Vessels in Acute Ischemic Stroke beyond Three Hours
07:30 AM - 12:00 PM Abstract 078 - Hyperglycemia and Perfusion in Acute MCA Occlusion
07:30 AM - 12:00 PM Abstract 079 - Variability in Determining Acute Stroke Lesion Volumes from ADC Maps
07:30 AM - 12:00 PM Abstract 080 - Use of Transcranial Doppler for the Detection of Severe Carotid Stenosis
07:30 AM - 12:00 PM Abstract 081 - Dual Energy CT Scan and Pathological Analysis of Ex-Vivo Carotid Plaque
07:30 AM - 12:00 PM Abstract 082 - Prevalence of Asymptomatic Intracranial Stenosis in US Elderly Population: Results from the Ultrasound Screening in Adults for Intracranial Disease (USAID) Study
07:30 AM - 12:00 PM Abstract 083 - MRI (DWI, T2, Flair Sequences) Findings of an Acute Ischemic Stroke in a 61 Year Old Patient Taken at Least 30 Minutes before Symptom Onset: A Case Report
07:30 AM - 12:00 PM Abstract 084 - Carotid Intima Media Thickness Does Not Correlate with Coronary Artery Atherosclerosis in Pakistani Population
07:30 AM - 12:00 PM Abstract 085 - CT Perfusion Imaging in Spectacular Shrinking Deficit
07:30 AM - 12:00 PM Abstract 086 - Transcranial Doppler Follow-Up after Intracranial Stenting
07:30 AM - 12:00 PM Abstract 087 - Association of Interleukin 1b and Volume of Acute Ischemic Infarct on Magnetic Resonance Imaging
07:30 AM - 12:00 PM Abstract 088 - Abnormal White Matter Structure Is Present in Regions of Vascular Steal Phenomenon in Patients with Arterial Steno-Occlusive Disease
07:30 AM - 12:00 PM Abstract 089 - The Predictive Value of Early Regional Changes of Cerebral Blood Flow for Ischemic Tissue Damage in an Embolic Rat Stroke Model
07:30 AM - 12:00 PM Abstract 090 - Metabolic and Diffusion Abnormalities of the Thalamus and Their Cognitive Correlates in Unilateral Sturge-Weber Syndrome
07:30 AM - 12:00 PM Abstract 091 - Are "Screening" MRI's for Asymptomatic NF-1 Patients Necessary or Cost Effective?
07:30 AM - 12:00 PM Abstract 092 - Cerebrovascular Reactivity in Children with Hematological Disorders Including Sickle Cell Disease
07:30 AM - 12:00 PM Abstract 093 - Headaches (HA) in Children and Adolescents (C/A) with Neurofibromatosis Type 1 (NF-I)
07:30 AM - 12:00 PM Abstract 094 - Childhood Stroke in Saudi Arabia: Etiology, Course and Recurrence Rates
07:30 AM - 12:00 PM Abstract 095 - Familial Pediatric Cavernous Malformation in a New Mexican Cohort-Clinical, Radiological and Pathologic Correlate
07:30 AM - 12:00 PM Abstract 096 - White Matter Reorganization in a Rat Model of Temporal Lobe Epilepsy Observed Using Enhanced MRI
07:30 AM - 12:00 PM Abstract 097 - MRI Structural Analysis of the Hippocampus in Families with Mesial Temporal Lobe Epilepsy
07:30 AM - 12:00 PM Abstract 098 - DTI Voxel-Based Analysis of Patients with Idiopathic Generalized Epilepsy
07:30 AM - 12:00 PM Abstract 099 - Voxel Based Morphometry Reveals Association between Gray Matter Loss and Dysfunctional Odor Identification in MTLE Patients
07:30 AM - 12:00 PM Abstract 100 - fMRI Validation of Novel MEG Expressive Language Tasks
07:30 AM - 12:00 PM Abstract 101 - Receptive Language Localization with Magnetic Source Imaging in Correlation with Electrical Cortical Stimulation
07:30 AM - 12:00 PM Abstract 102 - Relationship between MEG Spike Sources and fMRI Language Patterns in Children with Epilepsy
07:30 AM - 12:00 PM Abstract 103 - Conflicting Neuropsychological and Amytal Test Results: Outcomes in Temporal Lobectomies
07:30 AM - 12:00 PM Abstract 104 - Surgical Failure in Refractory MTLE Is Associated with Progression of Atrophy in Contralateral Hippocampus
07:30 AM - 12:00 PM Abstract 105 - Alterations of Intracerebral GABA Levels by Titration with Levetiracetam in Patients with Focal Epilepsies
07:30 AM - 12:00 PM Abstract 106 - Corpus Callosum "Silent" Atrophy in Relapsing Remitting Multiple Sclerosis Patients: A 7-Year Prospective Study
07:30 AM - 12:00 PM Abstract 107 - Functional and MRI Studies of Corpus Callosum (CC) in Relapsing-Remitting Multiple Sclerosis (RRMS)
07:30 AM - 12:00 PM Abstract 108 - Are Periventricular Lesions Specific for Multiple Sclerosis?
07:30 AM - 12:00 PM Abstract 109 - A Five-Year Serial Longitudinal Study of Deep Gray Matter Atrophy in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 110 - Brain Atrophy Predicts the Conversion from a Clinically Isolated Syndrome to Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 111 - A 3T MRI Investigation of the Topography of Whole Spinal Cord Atrophy in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 112 - Whole Brain and Tract-Specific Diffusion Tensor and Magnetization Transfer Imaging Values Correlate with Quantified Brain Atrophy
07:30 AM - 12:00 PM Abstract 113 - The Relationship between Spinal Cord Atrophy, Brain Atrophy, and Disability in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 114 - Benefits of Alemtuzumab Are Evident Even in Relapsing-Remitting Multiple Sclerosis Patients Who Experience Autoimmune Adverse Events
07:30 AM - 12:00 PM Abstract 115 - Natalizumab and Risk of Melanoma: A Prospective Follow-Up of Patients Treated by Natalizumab for Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 116 - Measurement of Yearly Change in RRMS Brain Volume Using 3T MRI Scans
07:30 AM - 12:00 PM Abstract 117 - Quantitative MRI Reveals Abnormality of Fornix and Cingulum in MS
07:30 AM - 12:00 PM Abstract 118 - Low Contrast Visual Stimuli Yield Differential Volumes of Functional MRI Activation in Affected and Unaffected Eyes Following Recovery from Optic Neuritis
07:30 AM - 12:00 PM Abstract 119 - Cerebral White and Grey Matter MRI Segmentation with Lesion In-Painting in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 120 - 3 Tesla Imaging of the Brain in Multiple Sclerosis Patients with Nystagmus - A New Diagnostic Tool
07:30 AM - 12:00 PM Abstract 121 - Imaging CNS Myelin by PET in Multiple Sclerosis Using the Thioflafin Derivative [11C]-PIB
07:30 AM - 12:00 PM Abstract 122 - Cerebral Activation Patterns Associated with Increased Working Memory Load in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 123 - Assessment of Neuronal Pathology in the Cerebral Grey Matter of Patients with MS: Added Value of PET with [11C]-Flumazenil
07:30 AM - 12:00 PM Abstract 124 - Focal Cerebral Increases of [alpha]-[11C]Methyl-L-Tryptophan Uptake Suggest Activation of the Kynurenine Pathway in Multiple Sclerosis: A PET Study
07:30 AM - 12:00 PM Abstract 125 - 24-Month Efficacy and Safety Outcomes from the TRANSFORMS Extension Study of Oral Fingolimod (FTY720) in Patients with Relapsing-Remitting Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 126 - Chronic Cerebrospinal Venous Insufficiency and Iron Deposition on Susceptibility-Weighted Imaging in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 127 - Triplestimulation in Patients with Clinical Isolated Syndromes: Sensitivity To Detect Clinically Silent Lesions in Comparison to Transcranial Magnetic Stimulation and Visual/Somatosensory Evoked Potentials
07:30 AM - 12:00 PM Abstract 128 - Hypoperfusion of Brain Parenchyma Is Strongly Associated with the Severity of Chronic Cerebrospinal Venous Insufficiency in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 129 - A Comparison of MS and Ischaemic Lesions as Visualised Using 7 Tesla T2* Phase Imaging
07:30 AM - 12:00 PM Abstract 130 - Impaired Motor Performance in MS Is Associated with Increased GABA Level in Sensorimotor Cortex
07:30 AM - 12:00 PM Abstract 131 - The Need for Standardization of Lesion Activity Analysis Categorization in the Multiple Sclerosis Clinical Trials
07:30 AM - 12:00 PM Abstract 132 - Assessing Brain Tissue Damage in Subjects with Radiologically Isolated Syndrome
07:30 AM - 12:00 PM Abstract 133 - Cine Cerebrospinal Fluid Imaging in Multiple Sclerosis. A Case-Control Study
07:30 AM - 12:00 PM Abstract 134 - DTI Correlates of Cognitive Dysfunction in Patients with Benign MS and with Clinically Isolated Syndrome
07:30 AM - 12:00 PM Abstract 135 - Detecting Multiple Sclerosis Cortical Lesions Post-Mortem Using 3, and 7 Tesla Magnetic Resonance Imaging
07:30 AM - 12:00 PM Abstract 136 - Multiple Sclerosis (MS) Patients, with and without Restless Legs Syndrome (RLS), Have Frequent Sleep Disturbances on Polysomnographic Studies
07:30 AM - 12:00 PM Abstract 137 - Quality of Life in Multiple Sclerosis Patients Is Associated with Poor Sleep as Assessed by Polysomnography
07:30 AM - 12:00 PM Abstract 138 - Clinical Pathway for the Differential Diagnosis of Daytime Sleepiness in MS Using Self-Administered Scales
07:30 AM - 12:00 PM Abstract 139 - Gene Expression Profiling of Post-Mortem Multiple Sclerosis Derived Normal Appearing White Matter and Active Lesion Tissue
07:30 AM - 12:00 PM Abstract 140 - HLA Allele Interactions Associated with Multiple Sclerosis Activity, Severity, and Progression
07:30 AM - 12:00 PM Abstract 141 - Familial Multiple Sclerosis, Does Consanguinity Has a Role?
07:30 AM - 12:00 PM Abstract 142 - NQO1 Inborn Gene Polymorphism and Suscepribility in Multiple Sclerosis
07:30 AM - 12:00 PM Abstract 143 - XYY Syndrome: A Possible Model for Autism Spectrum Disorder (ASD)
07:30 AM - 12:00 PM Abstract 144 - Polymorphism in Progranulin Gene Associated with Structural Differences in Brains of Normal Controls
07:30 AM - 12:00 PM Abstract 146 - Clinical Correlations of Asymmetric Temporal and Parietal Lobe Glucose Hypometabolism
07:30 AM - 12:00 PM Abstract 147 - Glucose Metabolism in Progressive Non-Fluent Aphasia Patients with Versus without Parkinsonism
07:30 AM - 12:00 PM Abstract 148 - Shape Analysis of the Neostriatum in Frontotemporal Lobar Degeneration, Alzheimer's Disease and Healthy Controls - Regional and Functionally Significant Atrophy
07:30 AM - 12:00 PM Abstract 149 - Spatial Localization of Densely Ischemic Regions Associated with Motor Extinction in Acute Stroke
07:30 AM - 12:00 PM Abstract 150 - Investigating the Relation between Basal Ganglia Volume and Intelligence
07:30 AM - 12:00 PM Abstract 151 - L[eacute]ger de Main: The Thalamus and the Automatic Limb
07:30 AM - 12:00 PM Abstract 152 - Primal Neuroanthropology - The Study of Archetypal Postures, Movements and Behavior in Sports and Related Activity That Connect Us to Our Evolution, Infancy, Neurodegeneration and Primordial Selves
07:30 AM - 12:00 PM Abstract 153 - Filial Catamenial Phantosmia
07:30 AM - 12:00 PM Abstract 154 - Surgical Resection of Hypothalamic Hamartomas for Severe Behavioral Symptoms
07:30 AM - 12:00 PM Abstract 155 - Early Exposure to Anti-Convulsants and the Development of Autism in Epilepsy
07:30 AM - 12:00 PM Abstract 156 - Visuo-Motor Deficits and Damage to White Matter Tracts in a Posterior Cortical Atrophy Patient
07:30 AM - 12:00 PM Abstract 157 - Olfactory Tract and Substantia Nigra Diffusion Tensor Imaging and Olfactory Function Testing in De Novo Parkinson's Disease
07:30 AM - 12:00 PM Abstract 158 - Clinical and DAT Imaging Characteristics of Parkinson's Disease Patients According to Their Smell Test Result
07:30 AM - 12:00 PM Abstract 159 - Volumetric MRI as an Image Biomarker for the Early Diagnosis of Parkinson's Disease
07:30 AM - 12:00 PM Abstract 160 - Volumetric Imaging Markers of Early Dementia in Older Patients with Parkinson's Disease
07:30 AM - 12:00 PM Abstract 161 - Functional MRI in De Novo Patients with Parkinson's Disease during a Self-Paced Simple Motor Task
07:30 AM - 12:00 PM Abstract 162 - A Novel Set Shifting fMRI Task Identifies Differences in Brain Activation in Parkinson's Disease and Healthy Controls
07:30 AM - 12:00 PM Abstract 163 - The Topographical Distribution of White Matter Damage in Parkinson's Disease and Progressive Supranuclear Palsy
07:30 AM - 12:00 PM Abstract 164 - The In-Vivo Topographical Distribution of Brain Tissue Loss Associated with Depression in Parkinson's Disease: A Voxel-Based Morphometry Study
07:30 AM - 12:00 PM Abstract 165 - Pattern of Global and Regional Brain Volume in Progressive Supranuclear Palsy Identified by MRI Using "Freesurfer" Post Processing Software
07:30 AM - 12:00 PM Abstract 166 - Comparison of Clinical Features and [18F]FP-CIT PET Findings between Drug-Induced Parkinsonism with and without Underlying Parkinson's Disease
07:30 AM - 12:00 PM Abstract 167 - Aging Effects of [18F]FP-CIT PET Measures in the Striatum of Drug Na[iuml]ve, De Novo PD Patients: Comparison with Normal Subjects
07:30 AM - 12:00 PM Abstract 168 - Baroreflex Sensitivity and Power Spectral Analysis during Autonomic Testing in Different Extrapyramidal Syndromes
07:30 AM - 12:00 PM Abstract 169 - Bulbar Function Is Correlated with Neuroimaging Outcomes in Parkinson's Disease
07:30 AM - 12:00 PM Abstract 170 - Symptomatic Correlation of [18F]FP-CIT PET Measures in PD Patients
07:30 AM - 12:00 PM Abstract 171 - Identifying Drugs for the Treatment of Spinocerebellar Ataxia Type 2 (SCA2)
07:30 AM - 12:00 PM Abstract 173 - Effects of Erythropoietin Single Dose Treatment in Patients with Friedreich Ataxia
07:30 AM - 12:00 PM Abstract 174 - The Emerging Role of Spinocerebellar Ataxia 17 in a Canadian Movement Disorders Clinic
07:30 AM - 12:00 PM Abstract 175 - Case Report: Human Immunodeficiency Virus Type 2 (HIV 2) and Ataxia
07:30 AM - 12:00 PM Abstract 176 - Retrospective Analysis of the Use of Varenicline (Chantix[reg]) in Ataxia
07:30 AM - 12:00 PM Abstract 177 - Case Report: Bilateral Ballism Following Postinfectious Meningoencephalitis with Demyelinating Polyneuropathy, Ophthalmoplegia, Bulbar Dysfunction, Areflexia, and Negative Anti-GQ1B Antibody
07:30 AM - 12:00 PM Abstract 178 - A Case of Subacute Encephalopathy, Ataxia and Myoclonus Due to Amantadine Toxicity in Chronic Renal Insufficiency
07:30 AM - 12:00 PM Abstract 179 - SCA-17 Presenting with an Unusually Mild Phenotype
07:30 AM - 12:00 PM Abstract 180 - Efficacy and Safety of Idebenone in a 6-Month US Phase 3 Clinical Study of Idebenone in Children with Friedreich's Ataxia
07:30 AM - 12:00 PM Abstract 181 - Parkin and Pink1 Promote DRP1-Mediated Mitochondrial Fssion in Cellular Models
07:30 AM - 12:00 PM Abstract 182 - Neuropathological and Biochemical Report of a Patient with a Parkin Mutation
07:30 AM - 12:00 PM Abstract 183 - LRRK2 G2019S Mutation in an Argentinean Cohort of Patients with Parkinson's Disease
07:30 AM - 12:00 PM Abstract 184 - PINK1 Mediates the Stress-Induced Degradation of Parkin
07:30 AM - 12:00 PM Abstract 185 - Mutations in the LRRK2 (G2019S) and the Glucocerebrosidase Genes Can Influence the Clinical Course and Pre-Morbid Behavior of Patients with Parkinson's Disease
07:30 AM - 12:00 PM Abstract 186 - Genetic Risk Factors for Cognitive Impairment in the DATATOP Cohort
07:30 AM - 12:00 PM Abstract 187 - Functional Polymorphisms of Human Dopamine Pathway Genes COMT, DBH and MAOB: A Pilot SNP Study of Single Gene Locus and Gene-Gene Interaction in Parkinson Disease
07:30 AM - 12:00 PM Abstract 188 - Progression of Motor Features in Elderly LRRK2 G2019S Non-Manifesting Carriers
07:30 AM - 12:00 PM Abstract 189 - Olfactory Loss in LRRK2 Related Parkinsonism
07:30 AM - 12:00 PM Abstract 190 - Mitochondrial Impairment in Manifesting LRRK2-G2019S Carriers
07:30 AM - 12:00 PM Abstract 191 - Olfactory Dysfunction Associated with LRRK2 G2019S Mutations
07:30 AM - 12:00 PM Abstract 192 - Parkinsonism and Progressive External Ophthalmoplegia with Multiple Mitochondrial DNA Deletions: Report of Two New Cases
07:30 AM - 12:00 PM Abstract 193 - New Mutations Identified in the SYNE1 Gene in ARCA-1 Patients
07:30 AM - 12:00 PM Abstract 194 - Systematic Integration of GWAS Data into Ongoing Meta-Analyses of Parkinson's Disease Genetic Association Studies
07:30 AM - 12:00 PM Abstract 196 - Ca2+ Channel Promiscuity of Small Conductance Ca2+-Activated K+ channels (SK) in Hippocampal Pyramidal Neurons
07:30 AM - 12:00 PM Abstract 197 - Differential Cellular Distribution of Acetyl CoA Synthetases in the Rat Brain: Implications for Ketogenic Diet Mediated Neuroprotection
07:30 AM - 12:00 PM Abstract 198 - Using SCN1A Gene Mutation Screening in Clinical Practice
07:30 AM - 12:00 PM Abstract 199 - Familial Cortical Myoclonic Tremor with Epilepsy (FCMTE): Mapping the Third Gene to 5p in a Large French Family: FCMTE 3
07:30 AM - 12:00 PM Abstract 200 - Lafora Disease: An Experience of 10 Years in the National Institute of Neurology and Neurosurgery, Mexico
07:30 AM - 12:00 PM Abstract 201 - Investigation of Bromodomain-Containing Protein 2 (BRD2) Gene Mutations in Photosensitive Epilepsy
07:30 AM - 12:00 PM Abstract 202 - Decreasing Presentations of Seizures to Emergency Departments in a Large Australian Population
07:30 AM - 12:00 PM Abstract 203 - Characteristics and Outcome of Post-Hypoxic Status Epilepticus
07:30 AM - 12:00 PM Abstract 204 - Risk Factors for the Development of Prolonged Status Epilepticus
07:30 AM - 12:00 PM Abstract 205 - Clinical Neurophysiologic and Genetic Presentation in Patients with Axonal Charcot-Marie-Tooth Disease
07:30 AM - 12:00 PM Abstract 206 - Increased Activity of Mutant TRPV4 Channels Is a Commom Feature in Both Scapuloperoneal Spinal Muscular Atrophy and Hereditary Motor and Sensory Neuropathy Type IIC
07:30 AM - 12:00 PM Abstract 207 - Development of the Pediatric Charcot-Marie-Tooth Disease Quality of Life Instrument (pCMT-QOL): An Outcome Measure for Clinical Trials
07:30 AM - 12:00 PM Abstract 208 - Development and Validation of the Charcot-Marie-Tooth Disease Pediatric (CMTPed) Scale
07:30 AM - 12:00 PM Abstract 209 - Axonal Deformities in a Mouse Model of Hereditary Neuropathy with Liability to Pressure Palsies (HNPP)
07:30 AM - 12:00 PM Abstract 210 - Novel Mutation in First Codon of Connexin 32 Causing CMT-X
07:30 AM - 12:00 PM Abstract 211 - Ethambutol Toxicity Exacerbating the Phenotype of CMT2A2
07:30 AM - 12:00 PM Abstract 212 - Phenotypic Characteristics of Hereditary Motor and Sensory Neuropathy Type VI (HMSN VI)
07:30 AM - 12:00 PM Abstract 213 - Phenotypical Features of 14 Moroccan Families with Autosomal Recessive Charcot-Marie-Tooth Disease Associated with Mutations in the GDAP1 Gene
07:30 AM - 12:00 PM Abstract 214 - Distribution of Charcot-Marie-Tooth Disease Subtypes and Frequency of Positive Genetic Testing Results
07:30 AM - 12:00 PM Abstract 215 - Allele-Specific Expression Changes in SNCA and GAK in Parkinson Disease Brain Tissue
07:30 AM - 12:00 PM Abstract 216 - Impact of Mutations in Parkin on Mitochondrial Function and Morphology
07:30 AM - 12:00 PM Abstract 217 - Spinocerebellar Ataxia Type 31 (SCA31) Is a Common Late-Onset Purely Cerebellar Ataxia
07:30 AM - 12:00 PM Abstract 218 - Cytochrome Oxidase Gene Variations and Their Potential Functional Consequences
07:30 AM - 12:00 PM Abstract 219 - Variation Databases for Neurodegenerative Disorders
07:30 AM - 12:00 PM Abstract 220 - Changes in MicroRNA Expression Profile in Mesial Temporal Sclerosis
07:30 AM - 12:00 PM Abstract 221 - Spinal Cord Atrophy Correlates with Clinical Disability in Friedreich Ataxia
07:30 AM - 12:00 PM Abstract 222 - Hematopoietic Stem Cell Transplantation for Adult-Onset Krabbe Disease: First Report in the Literature
07:30 AM - 12:00 PM Abstract 223 - Altered GABA Receptor Expression and Function in Fragile X Knockout Mice
07:30 AM - 12:00 PM Abstract 224 - Isolated Hexosaminidase B Deficiency in a Family with Late Onset Spinocerebellar Degeneration
07:30 AM - 12:00 PM Abstract 225 - Superior Cerebellar Peduncle Atrophy in Friedreich's Ataxia Correlates with Disease Symptoms
07:30 AM - 12:00 PM Abstract 226 - Neuroprotective Potential of DJ-1 in Neurodegenerative Diseases
07:30 AM - 12:00 PM Abstract 227 - Protein Analysis in Cells with Oxidative Phosphorylation Deficiency
07:30 AM - 12:00 PM Abstract 228 - Phenotypes of 117 Korean Patients with Mitochondrial Disorders
07:30 AM - 12:00 PM Abstract 229 - Maternally Inherited Spastic Paraplegia Due to a Mitochondrial DNA Mutation
07:30 AM - 12:00 PM Abstract 230 - Electrophysiological Evidence of Subclinical Multi-System Involvement in Pure OPA1 Autosomal Dominant Optic Atrophy
07:30 AM - 12:00 PM Abstract 231 - The "Ear of the Lynx" MRI Sign in Spastic Paraparesis with SPG 11 Mutations
07:30 AM - 12:00 PM Abstract 232 - Regional Brain Energy Deficit in a Preclinical Model of Huntington Disease: Presymptomatic Compensatory Mechanisms
07:30 AM - 12:00 PM Abstract 233 - Phenotype-Genotype Correlation of Four Novel Senataxin Gene Mutations in Hungarian Patients
07:30 AM - 12:00 PM Abstract 234 - Genetic Epidemiological and Clinicopathological Study of Familial and Sporadic Amyotrophic Lateral Sclerosis with FUS Mutations in the Japanese Population
07:30 AM - 12:00 PM Abstract 235 - Application of a Microarray-Based Whole Mitochondrial DNA Sequence Analysis for Molecular Diagnosis of Mitochondrial Diseases
07:30 AM - 12:00 PM Abstract 236 - TIMM8A 3`UTR Mutations in Subjects with Deafness and Dystonia May Affect TIMM8A Expression
07:30 AM - 12:00 PM Abstract 237 - The Phenotype of CADASIL in a Family with Hemozygous and Heterozygous Same R1231C Notch3 Mutation
07:30 AM - 12:00 PM Abstract 238 - Genetic Testing of Oxidative Phosphorylation Diseases: Comparison of Next Generation Sequencing with Capillary Sequencing Approaches
07:30 AM - 12:00 PM Abstract 239 - Lithium Reduces Cell Death in an In Vitro Model of Machado-Joseph Disease
07:30 AM - 12:00 PM Abstract 240 - Vitamin D Receptor Gene Confers Genetic Risks for Parkinson Disease
07:30 AM - 12:00 PM Abstract 241 - The PhenX Toolkit: Providing Standard Measures of Neurological Traits for Genome-Wide Association Studies
07:30 AM - 12:00 PM Abstract 243 - First Report of Frontotemporal Dementia-Like Phenotype in an Argentine Family with Presenilin-1 M146V Alzheimer's Disease with Pick Bodies
07:30 AM - 12:00 PM Abstract 244 - Histone Deacetylases Suppress CGG Repeat Induced Neurodegeneration in Drosophila Model of FXTAS
07:30 AM - 12:00 PM Abstract 245 - Apolipoprotein E Polymorphism and Age of Onset for Alzheimer's Disease in a Quadriethnic Sample
07:30 AM - 12:00 PM Abstract 246 - CALHM1 P86L Polymorphism Is Associated with Late-Onset Alzheimer's Disease under a Recessive Model
07:30 AM - 12:00 PM Abstract 247 - Genetic Variability in Cholesteryl Ester Transfer Protein (CETP) Is Independently Associated with Protection from Incident Dementia
07:30 AM - 12:00 PM Abstract 248 - Incidence of a Positive Family History in Genetic Prion Disease: Data from a Large Cohort
07:30 AM - 12:00 PM Abstract 249 - KIBRA: A Candidate Gene for Alzheimer's Disease with Implications for Memory
07:30 AM - 12:00 PM Abstract 250 - Dimebon (Latrepirdine) Does Not Enhance Cognition by Actions on Acetylcholinesterase or NMDA Receptor Modulation
07:30 AM - 12:00 PM Abstract 251 - Safety and Tolerability of a Once-Daily, Extended-Release Memantine Formulation (28 mg) in Patients with Moderate to Severe Alzheimer's Disease: Results of a 52-Week Open-Label Trial
07:30 AM - 12:00 PM Abstract 252 - Predictors of Adherence among Alzheimer's Disease Patients Receiving Oral Therapy: Results of a Retrospective Database Analysis
07:30 AM - 12:00 PM Abstract 253 - Effectiveness of Memantine in Patients with Moderate to Severe Alzheimer's Disease as Measured by the Caregiver Perceived Burden Questionnaire (CPBQ)
07:30 AM - 12:00 PM Abstract 254 - Donepezil's Effect on Cognition in Severe Alzheimer's Disease: A Pooled Data Analysis
07:30 AM - 12:00 PM Abstract 255 - Evaluating Cognitive Effects of Oral Rivastigmine Using Subscales and Items of the ADAS-Cog in Patients with Mild to Moderate Parkinson's Disease Dementia
07:30 AM - 12:00 PM Abstract 256 - Effects of Rivastigmine Transdermal Patch on Cognitive Ability in Patients with Mild-to-Moderately Severe Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 257 - Effects of Oral Rivastigmine on Specific Cognitive Abilities in Patients with Mild to Moderately Severe Alzheimer's Disease: A Pooled Analysis
07:30 AM - 12:00 PM Abstract 258 - Benefits of Extended-Release Memantine (28 mg, Once Daily) on Caregiver Distress: Results of a Multinational, Double-Blind, Placebo-Controlled Trial in Moderate to Severe Alzheimer's Disease
07:30 AM - 12:00 PM Abstract 259 - Dimebon (Latrepirdine) Promotes Neurite Outgrowth and Prevents Loss of Mitochondrial Membrane Potential in Cultured Hippocampal Neurons
07:30 AM - 12:00 PM Abstract 260 - Dimebon (Latrepirdine) Is Well-Tolerated in Patients with Alzheimer's Disease Receiving Memantine or Memantine Plus Donepezil
07:30 AM - 12:00 PM Abstract 261 - The Effects of Cholinesterase Inhibitors of Developing Dementia from Mild Cognitive Impairment
07:30 AM - 12:00 PM Abstract 262 - Recognition and Therapy of Tetrahydrobiopterin Deficiency (BH4) in Childhood Dystonia, a Spectrum of Dopa Responsive Disorders
07:30 AM - 12:00 PM Abstract 263 - Partial Trisomy 2p13.3-P16.3: Report of a Patient with Developmental Delay and Polymicrogyria, and Review of the Literature; a Shared Locus for Bilateral Perisylvian Polymicrogyria Narrowed to 2p16.1-P16.3
07:30 AM - 12:00 PM Abstract 264 - A Novel Congenital Disorder of Glycosylation Caused by Deficiency in ALG11 (ALG11-CDG)
07:30 AM - 12:00 PM Abstract 265 - L-Dopa Therapy in Angelman Syndrome of Childhood
07:30 AM - 12:00 PM Abstract 266 - Pyruvate Therapy on Leigh Syndrome Due to a Novel Mutation in PDH E1a Gene
07:30 AM - 12:00 PM Abstract 268 - Idebenone as a Potential Therapy for Ataxia with Oculomotor Apraxia Type I - Results of a One-Year N-of-1 Trial
07:30 AM - 12:00 PM Abstract 269 - Treatment of Pediatric Status Migrainosus: Can We Prevent the "Bounce Back"?
07:30 AM - 12:00 PM Abstract 270 - Mapping of Loci for Autistic Spectrum Disorder on Chromosomes 7q31.31-31.33 and 9q21.33-q22.2
07:30 AM - 12:00 PM Abstract 271 - Psychiatric Comorbidity and Management in Patients with Tuberous Sclerosis Complex
07:30 AM - 12:00 PM Abstract 272 - Serotonergic Modulation of Eye Movements in Sleep Assessed by Automated Detection
07:30 AM - 12:00 PM Abstract 273 - Slow Eye Movements in Light Sleep on the Maintenance of Wakefulness Test as a Marker of Sleepiness
07:30 AM - 12:00 PM Abstract 274 - Race-Ethnic Variation of Sleep Symptoms in an Urban Multi-Ethnic Cohort: The Northern Manhattan Study
07:30 AM - 12:00 PM Abstract 275 - Epworth Sleepiness Scale (ESS) and SleepMed Insomnia Index (SMI) as Outcome Measures in Treated Narcolepsy
07:30 AM - 12:00 PM Abstract 276 - Effect of Healthy Subjects' Age on Systemic Exposure to Armodafinil
07:30 AM - 12:00 PM Abstract 277 - Outcomes of Sodium Oxybate Therapy for Narcolepsy in an Out-Patient Sleep Clinic Population
07:30 AM - 12:00 PM Abstract 278 - Narcolepsy Risk in Relation to Alcohol and Caffeinated Beverage Consumption among Genetically Susceptible Individuals: A Population-Based Case-Control Study
07:30 AM - 12:00 PM Abstract 279 - Daytime Sleepiness Is Associated with Reduced Baroreflex Sensitivity in OSAS and Not in Narcolepsy
07:30 AM - 12:00 PM Abstract 280 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled fMRI Study of the Effect of Armodafinil on Prefrontal Cortical Activation in Patients with Residual Excessive Sleepiness Associated with CPAP-Treated OSA
07:30 AM - 12:00 PM Abstract 281 - Myotonic Dystrophy and Sleep-Disordered Breathing: Emergence of Severe Central Sleep Apnea after Initiation of Non-Invasive Positive Airway Pressure
07:30 AM - 12:00 PM Abstract 282 - Respiratory-Related Rhythmic Movements of Sleep (RRMS)
07:30 AM - 12:00 PM Abstract 283 - Circadian Rhythm of Core Body Temperature in an Animal Model of Chronic Epilepsy
07:30 AM - 12:00 PM Abstract 284 - Use of Sleep Medications Prior to Presentation to Sleep Clinic in Patients with Epilepsy and Insomnia: A Retrospective Study
07:30 AM - 12:00 PM Abstract 285 - Sleep Disorders in Children with Attention-Deficit/Hyperactivity Disorder (ADHD) Recorded over Night by Video-Polysomnography
07:30 AM - 12:00 PM Abstract 286 - Potential Mechanisms Underlying Spatial Learning and Memory Impairment Following Sleep Deprivation in Early Development
07:30 AM - 12:00 PM Abstract 287 - Shifting Demographics in REM Sleep Behavior Disorder: Sex Ratio, Antidepressants, and Autoimmunity
07:30 AM - 12:00 PM Abstract 288 - Self Perceived Personality Changes in Healthy Adults Reporting Dream Enactment Behavior
07:30 AM - 12:00 PM Abstract 289 - Sleep Disturbance, Dreams, Mood and Impulsive-Compulsive Behaviours in Parkinson's Disease
07:30 AM - 12:00 PM Abstract 290 - Sleep-Related Falling Out of Bed in Parkinson's Disease
07:30 AM - 12:00 PM Abstract 291 - Sleep Abnormalities in the Pallido-Ponto-Nigral Degeneration Kindred
07:30 AM - 12:00 PM Abstract 292 - Improvement in Multiple Symptoms of Fibromyalgia with Sodium Oxybate Treatment: Results from a US Phase 3 Randomized, Controlled Trial
07:30 AM - 12:00 PM Abstract 293 - Sodium Oxybate Reduces Pain and Improves Function and PGIC in Fibromyalgia: Results from an International, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
Faculty Disclosures
Jeremy D. Schmahmann, MD, FAAN Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Susan B. Bressman, MD, FAAN The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Oksana Suchowersky, MD, FAAN Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care.
Galen V. Henderson, MD No disclosure on file
Jeffrey L. Cummings, MD, FAAN Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia, Actinogen, Acumen, AlphaCognition, ALZpath, Aprinoia, AriBio, Artery, Biogen, Biohaven, BioVie, BioXcel, Bristol-Myers Squib, Cassava, Cerecin, Diadem, Eisai, GAP Foundation, GemVax, Janssen, Jocasta, Karuna, Lighthouse, Lilly, Lundbeck, LSP/eqt, Mangrove Therapeutics, Merck, NervGen, New Amsterdam, Novo Nordisk, Oligomerix, ONO, Optoceutics, Otsuka, Oxford Brain Diagnostics, Prothena, ReMYND, Roche, Sage Therapeutics, Signant Health, Simcere, sinaptica, Suven, TrueBinding, Vaxxinity, and Wren pharmaceutical, assessment, and investment companies. Dr. Cummings has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia, Biogen, Genentech, Grifols, Janssen, Karuna, Otsuka, reMYND, Roche, Signant Health. Dr. Cummings has stock in Artery, Vaxxinity, Behrens, Alzheon, MedAvante-Prophase, and Acumen. Dr. Cummings has received research support from NIH. Dr. Cummings has received research support from NIGMS. Dr. Cummings has received intellectual property interests from a discovery or technology relating to health care.
Gregory W. Albers, MD No disclosure on file
Gary S. Gronseth, MD, FAAN Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Bruce L. Miller, MD, FAAN Dr. Miller has nothing to disclose.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Laurie J. Ozelius, PhD The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Bradley F. Boeve, MD, FAAN Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
Ryan J. Uitti, MD, FAAN Dr. Uitti has nothing to disclose.
Karen S. Marder, MD, MPH, FAAN Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
James C. Grotta, MD, FAAN Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Michael E. Shy, MD, FAAN Dr. Shy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Shy has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DTx Pharma. The institution of Dr. Shy has received research support from NIH. The institution of Dr. Shy has received research support from Muscular Dystrophy Association. The institution of Dr. Shy has received research support from Charcot Marie Tooth Association. The institution of Dr. Shy has received research support from Applied Therapeutics.
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Katherine D. Mathews, MD, FAAN Dr. Mathews has received personal compensation for serving as an employee of Avidity Bioscience. The institution of Dr. Mathews has received research support from NIH. The institution of Dr. Mathews has received research support from Centers for Disease Control and Prevention. The institution of Dr. Mathews has received research support from Muscular Dystrophy Association . The institution of Dr. Mathews has received research support from Friedreich's Ataxia Research Alliance . The institution of Dr. Mathews has received research support from Sarepta . The institution of Dr. Mathews has received research support from Pfizer. The institution of Dr. Mathews has received research support from Reata . The institution of Dr. Mathews has received research support from PTC Therapeutics, Inc. The institution of Dr. Mathews has received research support from Italfarmaco . The institution of Dr. Mathews has received research support from AMO. The institution of Dr. Mathews has received research support from FibroGen. The institution of Dr. Mathews has received research support from Capricor. The institution of Dr. Mathews has received research support from edgewise. The institution of Dr. Mathews has received research support from biogen.
Geoffrey Manley, MD, PhD The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board.
Howard Yonas, MD No disclosure on file
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Rohit Bakshi, MD, FAAN Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Mitchell S. Elkind, MD, MS, FAAN Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Stefan M. Pulst, MD, FAAN Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for venrock. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Leverna. Dr. Pulst has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Pulst has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Leninthal LLC. The institution of Dr. Pulst has received research support from NINDS. Dr. Pulst has received intellectual property interests from a discovery or technology relating to health care.
Wendy Johnston, MD, FRCP(C), FAAN Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Johnston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Inc.. Dr. Johnston has a non-compensated relationship as a Board Member with ALS Canada that is relevant to AAN interests or activities. Dr. Johnston has a non-compensated relationship as a Chair with Canadian ALS Clinical Research Group that is relevant to AAN interests or activities.
John Shoffner IV, MD No disclosure on file
Massimo Filippi, MD, FAAN Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Anita L. Belman, MD, FAAN No disclosure on file
Harry Chugani, MD No disclosure on file
Brenda L. Banwell, MD, FAAN Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Martin R. Farlow, MD, FAAN No disclosure on file
David C. Tong, MD, FAHA No disclosure on file
Argye E. Hillis, MD, MA Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Alan R. Hirsch, MD, FACP Dr. Hirsch has nothing to disclose.
Steven Levine, MD, FAHA Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Charles H. Tegeler, MD Dr. Tegeler has nothing to disclose.
Bruno Dubois, MD No disclosure on file
David S. Knopman, MD, FAAN Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Norman Relkin, MD, PhD No disclosure on file
Patricia E. Penovich, MD, FAAN Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engage therapeutics. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for LVIS. Dr. Penovich has received personal compensation in the range of $0-$499 for serving as a Consultant for Monteris. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Therapeutics. Dr. Penovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Penovich has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Greenwich. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Biosciences. Dr. Penovich has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Penovich has a non-compensated relationship as a Comittee Member with American Epilepsy Society that is relevant to AAN interests or activities.
John A. Detre, MD Dr. Detre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hura Imaging. The institution of Dr. Detre has received research support from NIH. Dr. Detre has received personal compensation in the range of $500-$4,999 for serving as a grant proposal reviewer with NIH, VA, European Science Foundation,Deutsche Forschungsgemeinschaft.
David S. Liebeskind, MD, FAAN Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Samia J. Khoury, MD, FAAN Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk. Dr. Khoury has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ANA. Dr. Khoury has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Clinical Immunology. The institution of Dr. Khoury has received research support from MENACTRIMS. The institution of Dr. Khoury has received research support from NMSS. The institution of Dr. Khoury has received research support from Office of Naval Research USA. An immediate family member of Dr. Khoury has received intellectual property interests from a discovery or technology relating to health care.
Christine A. Wijman, MD No disclosure on file
Nancy Fischbein, MD Dr. Fischbein has received publishing royalties from a publication relating to health care.
Peter H. St George-Hyslop, MD, PhD Dr. St George-Hyslop has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TransitionBio. The institution of Dr. St George-Hyslop has received research support from NIH. Dr. St George-Hyslop has received intellectual property interests from a discovery or technology relating to health care.
Alisa Gean, MD No disclosure on file
Grace Yoon, MD Dr. Yoon has nothing to disclose.
Rossitza Chichkova, MD Dr. Chichkova has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Chichkova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Grifols. Dr. Chichkova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.
Latisha Sharma, MD Dr. Sharma has nothing to disclose.
Chitra Venkatasubramanian, MD, MBBS, MSc, FNCS Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell . Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKeen and associates. Dr. Venkatasubramanian has stock in Ceribell. The institution of Dr. Venkatasubramanian has received research support from Bard Inc. The institution of Dr. Venkatasubramanian has received research support from Biogen. The institution of Dr. Venkatasubramanian has received research support from NIH. The institution of Dr. Venkatasubramanian has received research support from Alnylam.
Jennifer J. Majersik, MD, FAAN Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Carmela Tartaglia, MD Dr. Tartaglia has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Tartaglia has received research support from NIH. The institution of Dr. Tartaglia has received research support from University of Toronto.
Senda Ajroud-Driss, MD, FAAN Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astrazeneca. Dr. Ajroud-Driss has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Ajroud-Driss has received research support from NIH. The institution of Dr. Ajroud-Driss has received research support from University of Minesota/FDA. The institution of Dr. Ajroud-Driss has received research support from Edgewise Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Biogen. The institution of Dr. Ajroud-Driss has received research support from Woolsey Pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Uniqure Biopharma. The institution of Dr. Ajroud-Driss has received research support from Coya Therapeutics. The institution of Dr. Ajroud-Driss has received research support from Novartis. The institution of Dr. Ajroud-Driss has received research support from Alnylam pharmaceuticals. The institution of Dr. Ajroud-Driss has received research support from Healey and AMG center for ALS . The institution of Dr. Ajroud-Driss has received research support from les Turner ALS Foundation. The institution of Dr. Ajroud-Driss has received research support from Hopewell. The institution of Dr. Ajroud-Driss has received research support from Peripheral neuropathy foundation. Dr. Ajroud-Driss has received publishing royalties from a publication relating to health care.
Nazli A. Janjua, MD, MBBS Dr. Janjua has nothing to disclose.
Howard L. Weiner, MD Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Scott W. Kraft, MD An immediate family member of Dr. Kraft has received personal compensation for serving as an employee of Bayer. An immediate family member of Dr. Kraft has received stock or an ownership interest from Bayer .
Jeffery Vance, MD, PhD Dr. Vance has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for neurology genetics.
Michael D. Geschwind, MD, PhD, FAAN Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Dennis W. Dickson, MD Dr. Dickson has nothing to disclose.
Clifford R. Jack, Jr., MD The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
Karen L. Furie, MD The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
James J. Sejvar, MD, FAAN Dr. Sejvar has nothing to disclose.
Bernardino Ghetti, MD No disclosure on file
Jawad F. Kirmani, MD Dr. Kirmani has nothing to disclose.
Steven G. Younkin, MD, PhD No disclosure on file
Joel Gutierrez, MD Dr. Gutierrez has nothing to disclose.
Douglas M. Wallace, MD No disclosure on file
Mario A. Saporta, MD, PhD, FAAN Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SwanBio. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharnext. Dr. Saporta has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Applied Therapeutics.
Marie Vidailhet, MD, PhD No disclosure on file
Khema R. Sharma, MBBS, FAAN Dr. Sharma has nothing to disclose.
Steven D. Brass, MD No disclosure on file
Meike Kasten, MD No disclosure on file
Nico J. Diederich, MD No disclosure on file
Erik K. St. Louis, MD The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Keith A. Josephs, Jr., MD, FAAN Dr. Josephs has nothing to disclose.
Imran I. Ali, MD, FAAN Dr. Ali has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for ABPN.
Jun Li, MD, PhD, FAAN The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Jong M. Rho, MD No disclosure on file
Mohit Neema, MD No disclosure on file
J. Paul Taylor, MD, PhD No disclosure on file
Fabienne M. Perren, MD No disclosure on file
Michael Chez, MD, FAAN Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
Elena Pegoraro, MD, PhD No disclosure on file
Wayne Martin, MD No disclosure on file
Richard M. Camicioli, MD, FAAN An immediate family member of Dr. Camicioli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi_Tenabi Canada. The institution of Dr. Camicioli has received research support from Canadian Institutes for Health Research. The institution of Dr. Camicioli has received research support from Western Foundation. The institution of Dr. Camicioli has received research support from NIH. The institution of an immediate family member of Dr. Camicioli has received research support from Brain Canada. The institution of an immediate family member of Dr. Camicioli has received research support from Pharmaceutical Sponsored Studies in ALS.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Li M. Li, MD No disclosure on file
Pasquale Montagna, MD No disclosure on file
Giuseppe Plazzi, MD The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TAKEDA. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOPROJET. The institution of Dr. Plazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for JAZZ. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA. The institution of Dr. Plazzi has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for OREXIA/CENTESSA.
Pietro Cortelli, MD, FAAN Dr. Cortelli has nothing to disclose.
Mya C. Schiess, MD, FAAN Dr. Schiess has nothing to disclose.
Caroline Moreau, MD No disclosure on file
David Devos The institution of Mr. Devos has received research support from Alterity.
Anat Achiron, MD, PhD, FAAN Dr. Achiron has nothing to disclose.
Ergun Y. Uc, MD An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Allan I. Levey, MD, PhD Dr. Levey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genuv. Dr. Levey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cognito Therapeutics. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna Pharmaceuticals. Dr. Levey has received stock or an ownership interest from NextSense. The institution of Dr. Levey has received research support from NIH. The institution of Dr. Levey has received research support from Biogen. The institution of Dr. Levey has received research support from Esai. The institution of Dr. Levey has received research support from AAN. The institution of Dr. Levey has received research support from State of Georgia. The institution of Dr. Levey has received research support from Novartis. The institution of Dr. Levey has received research support from Genentech. Dr. Levey has received intellectual property interests from a discovery or technology relating to health care. Dr. Levey has received personal compensation in the range of $500-$4,999 for serving as a NAPA Avisory Committee Co-Chair with US Dept of Health and Human Services.
Felix Bermejo-Pareja, MD No disclosure on file
No disclosure on file
Daria A. Trojan, MD No disclosure on file
Jan O. Aasly, MD, PhD No disclosure on file
Alrabi Tawil, MD, FAAN Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Tawil has received personal compensation in the range of $500-$4,999 for serving as a Consultant for meRicule. The institution of Dr. Tawil has received research support from Friends of FSH Research. The institution of Dr. Tawil has received research support from FSH Society. The institution of Dr. Tawil has received research support from NIH. The institution of Dr. Tawil has received research support from Fulcrum. Dr. Tawil has received intellectual property interests from a discovery or technology relating to health care.
Julie A. Fields, BA No disclosure on file
Byung-Ok Choi, MD, PhD No disclosure on file
Alexis Brice, MD Dr. Brice has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for ICM.
Katherine P. Rankin, PhD The institution of Dr. Rankin has received research support from Marcus Foundation.
Gabrielle A. DeVeber, MD Dr. DeVeber has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for GDEV consultants inc.
William J. Logan, MD Dr. Logan has nothing to disclose.
Andrew M. Demchuk, MD Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lumosa. Dr. Demchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Pfizer/BMS. Dr. Demchuk has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Demchuk has received stock or an ownership interest from Circle NVI. Dr. Demchuk has received intellectual property interests from a discovery or technology relating to health care.
Carlo Caltagirone No disclosure on file
Alejandro A. Rabinstein, MD, FAAN Dr. Rabinstein has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shionogi . Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Chiesi. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ceribell. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurocritical care/NCS-Springer. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters/UptoDate. Dr. Rabinstein has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO/DynaMed. Dr. Rabinstein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care. Dr. Rabinstein has received publishing royalties from a publication relating to health care.
Clementine Karageorgiou, MD The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for GENESIS PHARMA. The institution of Dr. Karageorgiou has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for TEVA-SPECIFAR.
Frederic Dubas, PrMD No disclosure on file
Judith L. Ross, MD No disclosure on file
Nicolas Dupre, MD, FAAN Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Jean-Marc Olivot No disclosure on file
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Vincenzo Silani, MD, FAAN Dr. Silani has nothing to disclose.
Maria J. Molnar, MD, PhD Dr. Molnar has nothing to disclose.
Michael G. Dwyer III, MD, PhD Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Maher Saqqur, MD Dr. Saqqur has nothing to disclose.
Heinz Reichmann, MD, FAAN Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zambon. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme. Dr. Reichmann has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wissenschaftsverlag.
Hanna Rosenmann No disclosure on file
Julien Praline No disclosure on file
Marie Sarazin No disclosure on file
Bruce I. Ovbiagele, MD, MSc, FAAN Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Guy A. Rouleau, MD, PhD, FAAN Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Brian Silver, MD, FAAN Dr. Silver has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various legal firms. Dr. Silver has received intellectual property interests from a discovery or technology relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received publishing royalties from a publication relating to health care. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Women's Health Initiative. Dr. Silver has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Best Doctors, Inc./Teladoc, Inc.. Dr. Silver has a non-compensated relationship as a Consultant with ABPN that is relevant to AAN interests or activities. Dr. Silver has a non-compensated relationship as a Member, Regional Board of Directors with American Heart Association that is relevant to AAN interests or activities.
Federica Agosta Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Jordan J. Elm The institution of Dr. Elm has received research support from NIH.
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
Stuart D. Cook, MD, FAAN No disclosure on file
Bennett L. Lavenstein, MD, FAAN No disclosure on file
Erik K. Henricson, MPH No disclosure on file
Nilufer Taner, MD, PhD, FAAN The institution of Dr. Taner has received research support from NIH.
Chong S. Lee, MD, FRCPC Dr. Lee has nothing to disclose.
Juan Carlos Gomez Esteban, MD Dr. Gomez Esteban has nothing to disclose.
Guy J. Buckle, MD No disclosure on file
Duk L. Na, MD No disclosure on file
Maria Alejandra Gonzalez Duarte, MD, FAAN Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Carlos Cantu, MD, MSc Dr. Cantu has nothing to disclose.
Charles R. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Bonnie Glanz The institution of Ms. Glanz has received research support from CMSC. The institution of Ms. Glanz has received research support from NIH.
Stephen B. Shrewsbury, MD Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Susan L. Perlman, MD Dr. Perlman has nothing to disclose.
Alyx B. Porter, MD, FAAN Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Nathaniel F. Watson, MD Dr. Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for React Health. Dr. Watson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony Biosciences.
Linda Teri No disclosure on file
Ann M. Schmeichel Ann M. Schmeichel has nothing to disclose.
Zbigniew K. Wszolek, MD, FAAN Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica. Dr. Wszolek has received intellectual property interests from a discovery or technology relating to health care.
Anamarli Nucci No disclosure on file
Kelly Sullivan, PhD Dr. Sullivan has received intellectual property interests from a discovery or technology relating to health care.
Jun Goto, MD, PhD No disclosure on file
Niels Bergsland Prof. Bergsland has nothing to disclose.
Sanjay Kalra, MD The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
Rosalia C. Silvestri-Hobson, MD No disclosure on file
Maria C. Zurru, MD No disclosure on file
Franz Fazekas, MD No disclosure on file
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and 好色先生 in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . The institution of Dr. Boulos has received research support from Zoll Itamar. The institution of Dr. Boulos has received research support from Toronto Dementia Research Alliance. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lundbeck.
Fuqiang Gao, MD Dr. Gao has nothing to disclose.
Maria Damiano, MD No disclosure on file
Hugh Kearney, MD, PhD Dr. Kearney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Hidehiro Mizusawa, MD, PhD No disclosure on file
Thierry Maisonobe No disclosure on file
Rhoda Au, PhD Dr. Au has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Au has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Au has received publishing royalties from a publication relating to health care. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Davos Alzheimer's Collaborative. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with High Lantern.
Alan M. Mandell, MD No disclosure on file
Mohammed Aldosari, MD, ABP, ABPN No disclosure on file
Jose G. Romano, MD, FAAN Dr. Romano has stock in Vycor Medical/NovaVision. The institution of Dr. Romano has received research support from NIH/NINDS. The institution of Dr. Romano has received research support from NIH/NHLBI.
Marianne De Visser, MD, PhD Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. De Visser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. De Visser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca.
Todd J. Swick, MD, FAAN Dr. Swick has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Swick has stock in Takeda Pharmaceuticals.
Michael Hoffmann, MD, FCP, FAHA, FAAN No disclosure on file
Zhigao Huang, MD, PhD No disclosure on file
Catherine Lubetzki Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MERCK SERONO. Catherine Lubetzki has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for REWIND.
Philippe Couratier, PhD Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Couratier has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Couratier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier .
Paul M. Thompson, PhD No disclosure on file
Eldad Melamed, MD No disclosure on file
John D. Fisk, PhD The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care.
Akihiro Yugeta, MD No disclosure on file
Michelle S. Troche, PhD No disclosure on file
David G. Munoz, MD No disclosure on file
Teodoro Del Ser Escribano, PhD No disclosure on file
Elham Bayat, MD Dr. Bayat has nothing to disclose.
Thomas H. Mosley, PhD No disclosure on file
Colin Doherty, MD The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland.
Hiroyuki Ishiura, MD No disclosure on file
Myriam Fornage Myriam Fornage has nothing to disclose.
Michael Tocco No disclosure on file
Pierre Tariot Pierre Tariot has received personal compensation for serving as an employee of Banner Alzheimer's Institute. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WebMD. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arcadia. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioXcel. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cortexyme. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Pierre Tariot has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eNOVA. Pierre Tariot has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Pierre Tariot has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos. Pierre Tariot has received intellectual property interests from a discovery or technology relating to health care.
Deborah Raymond The institution of Ms. Raymond has received research support from NIH.
William B. Dobyns, MD No disclosure on file
Diego Cadavid, MD, FAAN Dr. Cadavid has received personal compensation for serving as an employee of Verge Genomics. Dr. Cadavid has received personal compensation for serving as an employee of Vertex Pharmaceuticals. Dr. Cadavid has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Cadavid has or had stock in Verge Genomics.Dr. Cadavid has or had stock in Vertex Pharmaceuticals.
Leo Wolansky, MD The institution of Dr. Wolansky has received research support from Guerbet.
Paul Ruggieri, MD Dr. Ruggieri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Cleveland Clinic.
Emmanuelle Apartis, MD No disclosure on file
Alfredo Thomson, MD Dr. Thomson has nothing to disclose.
Ricardo F. Allegri, MD, PhD, FAAN Dr. Allegri has nothing to disclose.
Frank L. Silver, MD Dr. Silver has nothing to disclose.
Bernadette Boden-Albala, DrPH Ms. Boden-Albala has received research support from NIH.
Francisco M. Branco Germiniani, MD Dr. Branco Germiniani has nothing to disclose.
Frances E. Jensen, MD, FAAN Dr. Jensen has received research support from Passages Bio.
Clinton B. Wright, MD, FAAN An immediate family member of Dr. Wright has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Wright has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Abali Milne Kalil. Dr. Wright has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Wright has received personal compensation in the range of $500-$4,999 for serving as a surveyor with ASTRO.
Lorraine N. Clark, PhD No disclosure on file
Nirit Lev, MD No disclosure on file
Wenbo Zhang, MD, PhD No disclosure on file
Deanna Dickens, MD No disclosure on file
Frank J. Ritter, MD No disclosure on file
Gail L. Risse, PhD No disclosure on file
Elsdon Storey, FRACP, DPhil No disclosure on file
Youngbin Choi, MD No disclosure on file
Katie M. Wiltshire, MD No disclosure on file
A. D. Rothner, MD No disclosure on file
Robert A. Bermel, MD, FAAN Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Jonathan Haines, MD No disclosure on file
Eli Diamond, MD Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation.
Celia H. Tengan, MD No disclosure on file
Beatriz H. Kiyomoto No disclosure on file
Richard K. Bogan, MD Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz Pharmaceutical . Dr. Bogan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Takeda. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome . Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Harmony. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Bogan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Axsome. Dr. Bogan has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Jazz. The institution of Dr. Bogan has received research support from Jazz Pharmaceuticals. The institution of Dr. Bogan has received research support from Harmony . The institution of Dr. Bogan has received research support from Eisai. The institution of Dr. Bogan has received research support from Avadel. The institution of Dr. Bogan has received research support from Takeda. The institution of Dr. Bogan has received research support from Suven. The institution of Dr. Bogan has received research support from Axsome. The institution of Dr. Bogan has received research support from Merck. The institution of Dr. Bogan has received research support from Liva Nova. The institution of Dr. Bogan has received research support from Nyxoah. Dr. Bogan has received research support from Bayer. Dr. Bogan has received intellectual property interests from a discovery or technology relating to health care.
Philip De Jager, MD, PhD Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
John A. Lucas John A. Lucas has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Clinical Neuropsychology.
Teepu Siddique, MD, FAAN No disclosure on file
Jianhua Yan, PhD No disclosure on file
Robert H. Edwards, MD No disclosure on file
Mac McLaughlin, MD Dr. McLaughlin has nothing to disclose.
Timothy E. Lotze, MD, FAAN Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Rachel J. Saunders-Pullman, MD The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Najeeb S. Qadi, MD No disclosure on file
Manuel M. Buitrago Blanco, MD, PhD No disclosure on file
Frederick A. Schmitt, PhD The institution of Dr. Schmitt has received research support from NIH.
Cornelia Laule, PhD The institution of Dr. Laule has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Laule has received research support from Natural Sciences and Engineering Research Council of Canada (NSERC). The institution of Dr. Laule has received research support from International Collaboration on Repair Discoveries (ICORD).
Kristine M. Chapman, MD No disclosure on file
Ken Uchino, MD Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aboott Laboratories, Inc.. Dr. Uchino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACP JOURNAL CLUB. The institution of Dr. Uchino has received research support from NIH.
Salvatore Spina, MD Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert.io. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lumanity. Dr. Spina has received research support from Tau Consortium. Dr. Spina has received research support from Chan Zuckerberg Initiative, LLC. Dr. Spina has received research support from Bluefield Project to Cure FTD. Dr. Spina has received research support from NIH. Dr. Spina has received research support from Larry L. Hillblom Foundation. Dr. Spina has received personal compensation in the range of $500-$4,999 for serving as a Invited Speaker with Peking Union Medical Center Hospital.
Hermann Stefan, MD, PhD No disclosure on file
Catherine L. Gallagher, MD Dr. Gallagher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic.
Han-Xiang Deng, MD Dr. Deng has nothing to disclose.
Venkata S. Dandamudi, MD No disclosure on file
Yong Shi, PhD No disclosure on file
Albert Jin, MD No disclosure on file
Frans Brugman, MD No disclosure on file
Andrew Krystal, MD No disclosure on file
Jeffrey C. Looi, MD No disclosure on file
Leslie A. Morrison, MD, FAAN No disclosure on file
nobl barazangi, MD, PhD Dr. Barazangi has nothing to disclose.
Vicki Shanker, MD, FAAN Dr. Shanker has received personal compensation in the range of $0-$499 for serving as a Consultant for The Insighters.
Nizar Chahin, MD Dr. Chahin has nothing to disclose.
David Wack, PhD No disclosure on file
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Clifton L. Gooch, MD, FAAN Dr. Gooch has received publishing royalties from a publication relating to health care. Dr. Gooch has received publishing royalties from a publication relating to health care.
Mark J. Gorman, MD, FAAN No disclosure on file
John R. Sims, MD Dr. Sims has received personal compensation for serving as an employee of Eli Lilly and Company. Dr. Sims has stock in Eli Lilly and Company.
Christopher Walsh, MD, PhD Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Maze therapeutics. Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Third Rock Ventures. Dr. Walsh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Flagship Pioneering. Dr. Walsh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology.
Kinan K. Hreib, MD No disclosure on file
Nir Giladi, MD, FAAN Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
Hyunmi Choi, MD Dr. Choi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsy Research by Elsevier. The institution of Dr. Choi has received research support from National Institute of Aging.
Nathan Pankratz, PhD No disclosure on file
Shigeo Murayama, MD, PhD No disclosure on file
Peter J. Koudstaal, MD No disclosure on file
Albert Hofman, MD, PhD No disclosure on file
Monique M. Breteler, MD, PhD No disclosure on file
Stephen M. Graham, PhD No disclosure on file
Anton P. Porsteinsson, MD Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Porsteinsson has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Functional Neuromodulation. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Porsteinsson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognitive Research Corporation. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Athira. Dr. Porsteinsson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Porsteinsson has received research support from Alector. The institution of Dr. Porsteinsson has received research support from Eisai. The institution of Dr. Porsteinsson has received research support from Eli Lilly. The institution of Dr. Porsteinsson has received research support from Athira. The institution of Dr. Porsteinsson has received research support from Genentech/Roche. The institution of Dr. Porsteinsson has received research support from Cassava. The institution of Dr. Porsteinsson has received research support from Vaccinex.
William C. Nichols, PhD No disclosure on file
Tatiana Foroud, PhD The institution of Dr. Foroud has received research support from NIH. The institution of Dr. Foroud has received research support from Michael J. Fox Foundation. The institution of Dr. Foroud has received research support from Parkinson Foundation. Dr. Foroud has received personal compensation in the range of $500-$4,999 for serving as a Member of an Advisory Committee with Mayo Clinic, University of Pennsylvania, Allen Institute, Mt. Sinai, Van Andel Institute.
Isak Prohovnik, PhD No disclosure on file
Shree Pandya, DPT No disclosure on file
Brian J. Murray, MD, FAAN The institution of Dr. Murray has received research support from Wake Up Narcolepsy. Dr. Murray has received publishing royalties from a publication relating to health care.
Wim L. Robberecht, MD, PhD No disclosure on file
Vladimir S. Kostic, MD, PhD Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche. An immediate family member of Dr. Kostic has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Alkaloid. The institution of Dr. Kostic has received research support from Ministry of 好色先生, Science and Technological Development of Serbia.
Jeffrey Statland, MD Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ML Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epic Bio. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Armatus . Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kate Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vita Therapeutics. Dr. Statland has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dyne Therapeutics. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum Therapeutics. Dr. Statland has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Statland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex . The institution of Dr. Statland has received research support from NIH. The institution of Dr. Statland has received research support from FSHD Society. The institution of Dr. Statland has received research support from Friends of FSH Research. The institution of Dr. Statland has received research support from FSHD Canada. The institution of Dr. Statland has received research support from MDA.
Martina Vendrame, MD PhD Dr. Vendrame has nothing to disclose.
Marta San Luciano, MD, FAAN Dr. San Luciano has received research support from NIH (NINDS). Dr. San Luciano has received research support from Raynor Cerebellum Project.
Clarissa L. Yasuda, MD, PhD Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Mario Mascalchi, MD No disclosure on file
David R. Lynch, MD, PhD The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Emilia M. Gatto, MD, FAAN Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving as a Consultant for Bago Argentina. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bago. Dr. Gatto has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Gatto has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Janssen. Dr. Gatto has received research support from Roche. The institution of Dr. Gatto has received research support from CHDI.
Odile Dubourg, MD No disclosure on file
George Bartzokis, MD No disclosure on file
Matthew J. Baker, MD No disclosure on file
Ronald J. Killiany, PhD Dr. Killiany has nothing to disclose.
Marios Hadjivassiliou Marios Hadjivassiliou has nothing to disclose.
Paolo Del Dotto, MD No disclosure on file
Maaike M. Van Der Graaff No disclosure on file
Johannes Jakobsen, MD, DMSci The institution of Dr. Jakobsen has received research support from TAKEDA. Dr. Jakobsen has received publishing royalties from a publication relating to health care. Dr. Jakobsen has received personal compensation in the range of $5,000-$9,999 for serving as a Advisor with Danish Medicine Counsil.
Yu-Tze Ng, MD, FRACP, FAAN No disclosure on file
Carla Tortorella No disclosure on file
Alcibiades Rodriguez, MD No disclosure on file
Rebecca F. Gottesman, MD, PhD The institution of Dr. Gottesman has received research support from NIH.
Amy E. Sanders, MD, FAAN Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis Pharmaceuticals. Dr. Sanders has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Adlarity. Dr. Sanders has a non-compensated relationship as a Medical and Scientific Advisory Board with Alzheimer's Association (CT Chapter) that is relevant to AAN interests or activities. Dr. Sanders has a non-compensated relationship as a Board Member with UCNS that is relevant to AAN interests or activities.
Marilou I. Ching, MD Dr. Ching has nothing to disclose.
Nozomu Sato, MD No disclosure on file
Adam B. Cohen, MD Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Thirty Madison. Dr. Cohen has received stock or an ownership interest from Thirty Madison.
Batool Kirmani, MD, FAAN No disclosure on file
Richard Leigh, MD The institution of Dr. Leigh has received research support from National Institutes of Health. The institution of Dr. Leigh has received research support from American Heart Association. Dr. Leigh has received intellectual property interests from a discovery or technology relating to health care.
Gustavo Figueira, MD No disclosure on file
Koichi Okamoto, MD, PhD No disclosure on file
George Grossberg, MD Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Grossberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newron. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oligomerix. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quince. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. The institution of Dr. Grossberg has received research support from NIA. The institution of Dr. Grossberg has received research support from Functional Neuromodulation .
Samit Hirawat No disclosure on file
Sanjeev Sivakumar, MD Dr. Sivakumar has stock in LLY. Dr. Sivakumar has stock in Abbott Labs. Dr. Sivakumar has stock in Abbvie.
Adriana C. Bermeo Ovalle, MD, FAAN An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis Inc.. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for SK Life Science. An immediate family member of Dr. Bermeo Ovalle has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal on Clinical Neuropysiology. An immediate family member of Dr. Bermeo Ovalle has received publishing royalties from a publication relating to health care.
Wei Liu, MD Dr. Liu has nothing to disclose.
Patrizia Amati-Bonneau No disclosure on file
Ashish Arora, MD No disclosure on file
Dominique Bonneau No disclosure on file
Christopher Cunniff, MD No disclosure on file
Stephanie Debette, MD, PhD No disclosure on file
Danyella Dogini, PhD No disclosure on file
Brittany Dugger, BS No disclosure on file
Jose Luis Etcheverry, MD No disclosure on file
Gereon Fink No disclosure on file
Jill S. Goldman, MS MPhil CGC No disclosure on file
Daniela Grimaldi, MD No disclosure on file
Jaesung Kim, MD No disclosure on file
Mohammad Ikram The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
Anna Karydas No disclosure on file
Melissa Murray, PhD Dr. Murray has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avid Radiopharmaceuticals. The institution of Dr. Murray has received research support from National Institute on Aging. The institution of Dr. Murray has received research support from Alzheimer's Association. The institution of Dr. Murray has received research support from Chan Zuckerberg Initiative.
John Listerud, MD No disclosure on file
Joan Mackell No disclosure on file
Yusuke Niimi No disclosure on file
Hiroshi Otsubo No disclosure on file
Elizabeth Pang No disclosure on file
Mikolaj Pawlak, MD PhD Dr. Pawlak has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgalign . Dr. Pawlak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Inteneural Networks Inc. Dr. Pawlak has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RSQ. Dr. Pawlak has received publishing royalties from a publication relating to health care.
Gabriel Persi Gabriel Persi has nothing to disclose.
Rosa Rademakers, PhD Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mayo Clinic. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Rosa Rademakers, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Alzheimer Fondation. Rosa Rademakers, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Kisick Family Foundation (FTD grant program). The institution of Rosa Rademakers, PhD has received research support from NIH. The institution of Rosa Rademakers, PhD has received research support from DOD. The institution of Rosa Rademakers, PhD has received research support from Flanders Institute for Biotechnology (VIB). The institution of Rosa Rademakers, PhD has received research support from Flanders Funds for Scientific Research.
Patricia M. Riccio, MD No disclosure on file
Luis D. Medina, PhD The institution of Dr. Medina has received research support from National Institutes of Health. Dr. Medina has received personal compensation in the range of $500-$4,999 for serving as a Speaker with AbbVie. Dr. Medina has a non-compensated relationship as a Council Member with Alzheimer's Association that is relevant to AAN interests or activities.
Thomas Meier, PhD No disclosure on file
Langdon Miller, MD No disclosure on file
Fanny Mochel, MD Dr. Mochel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx.
I. Jon Russell No disclosure on file
Raam Sambandam, MD No disclosure on file
Rodolfo Savica, MD, PhD, FAAN The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.
Rosemary R. Shy, MD No disclosure on file
Ryan W. Snider No disclosure on file
Audrey Strongosky No disclosure on file
Massanobu Takatani, MD No disclosure on file
Jo Anne Turner, APRN No disclosure on file
James F. Bartscher, MD Dr. Bartscher has nothing to disclose.
John Ratchford, MD Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Marcia E. Morita-Sherman, MD An immediate family member of Dr. Morita-Sherman has received personal compensation for serving as an employee of Forrester Research. Dr. Morita-Sherman has received personal compensation for serving as an employee of Eisai Inc.. An immediate family member of Dr. Morita-Sherman has stock in Forrester Research. The institution of Dr. Morita-Sherman has received research support from Cleveland Clinic.
Kaili Stanley No disclosure on file
David N. Franz, MD No disclosure on file
Michael W. Devereaux, MD, FAAN Dr. Devereaux has received personal compensation for serving as an employee of DigiTrace part of Sleepmed. Dr. Devereaux has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kevin Trangle and Associates.
Paul R. Carney, MD No disclosure on file
Jonathan Kleinman, MD Dr. Kleinman has nothing to disclose.
Peter B. Barker, MD No disclosure on file
Ryan T. Merrell, MD No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Victor Zach, MD No disclosure on file
Divya Gupta, MD No disclosure on file
Carlos A. Guerreiro, MD, FAAN No disclosure on file
Craig McDonald, MD Dr. McDonald has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Biosciences. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Edgewise Therapeutics. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.
Hesham M. Al-Dhalaan, MD No disclosure on file
James Y. Garbern, MD, FAAN No disclosure on file
Dag Aarsland, MD Dr. Aarsland has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics.
Erica C. Camargo Faye, MD, PhD No disclosure on file
Herminia D. Rosas, MD No disclosure on file
Phyllis Grable-Esposito, MD No disclosure on file
Siong-Chi Lin, MD No disclosure on file
Sarah E. Zauber, MD, FAAN Dr. Zauber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ascel Health. The institution of Dr. Zauber has received research support from Abbive. The institution of Dr. Zauber has received research support from Abbott. Dr. Zauber has received personal compensation in the range of $500-$4,999 for serving as a Site Visitor with Parkinson Foundation.
William K. Scott, MD No disclosure on file
Peter K. Todd, MD, PhD, FAAN Dr. Todd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REATA Therapeutics. Dr. Todd has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal services. Dr. Todd has or had stock in Denali Therapeutics. The institution of Dr. Todd has received research support from NIH. The institution of Dr. Todd has received research support from VA. The institution of Dr. Todd has received research support from Ann Arbor Against ALS. The institution of Dr. Todd has received research support from Packard Foudation. Dr. Todd has received intellectual property interests from a discovery or technology relating to health care. Dr. Todd has received publishing royalties from a publication relating to health care. Dr. Todd has received personal compensation in the range of $500-$4,999 for serving as a ANA Highlights module director with American Neurological Association.
Qi Li, MD, PhD No disclosure on file
Oliver E. Bandmann, MD, PhD, FAAN No disclosure on file
Istvan Katona No disclosure on file
Carly Siskind, MS Ms. Siskind has nothing to disclose.
Philippe Corcia, MD No disclosure on file
Leslie C. Baxter, PhD No disclosure on file
Juan R. Sanchez-Ramos, MD, PhD No disclosure on file
Eloi Magnin No disclosure on file
Luiz E. Betting Dr. Betting has nothing to disclose.
Paolo Zamboni, MD No disclosure on file
Bruno Lenne, PhD No disclosure on file
Antonia Ceccarelli, MD, PhD No disclosure on file
Rufus O. Akinyemi, MD Dr. Akinyemi has nothing to disclose.
Rana Assouad, MD No disclosure on file
Bruno Stankoff, MD, PhD The institution of Bruno Stankoff, MD, PhD has received research support from Roche, Sanofi, Serono . The institution of Bruno Stankoff, MD, PhD has received research support from Novartis.
Robert Laforce, Jr., MD, PhD Dr. Laforce has nothing to disclose.
Michel Bottlaender Michel Bottlaender has nothing to disclose.
David Seder, MD No disclosure on file
Vladimiro Sinay, MD No disclosure on file
Daniel A. Drubach, MD, FAAN No disclosure on file
David Bradley, MD Dr. Bradley has nothing to disclose.
Marilisa M. Guerreiro, MD No disclosure on file
Shirley Chen, DO No disclosure on file
Ritsuko Hanajima, MD, PhD No disclosure on file
Juliana Setyawan, PharmD, MS No disclosure on file
Christof Karmonik, PhD No disclosure on file
Richard McLachlan, MD No disclosure on file
David J. Mikulis, MD Dr. Mikulis has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Neinstein Personal Injury Lawyers. Dr. Mikulis has received stock or an ownership interest from Thornhill Medical, Inc.. Dr. Mikulis has received intellectual property interests from a discovery or technology relating to health care.
Chikkathur N. Madhavarao, PhD No disclosure on file
Aleksandar Rakovic No disclosure on file
Katherine A. James, PhD No disclosure on file
Lauren C. Hyams, PhD No disclosure on file
Genevieve Langley No disclosure on file
Aziza Chedrawi, MD No disclosure on file
Raffaella Migliaccio Raffaella Migliaccio has nothing to disclose.
Marc Sollberger, MD No disclosure on file
Michael D. Frost, MD No disclosure on file
Paolo Vitali, MD Dr. Vitali has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Vitali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novonordisk. Dr. Vitali has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Vitali has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BTX.
Kathryn H. Rosenbluth, PhD Dr. Rosenbluth has received personal compensation for serving as an employee of Cala Health. Dr. Rosenbluth has stock in Cala Health.
Diamanto Tsakanikas, PhD No disclosure on file
Jeff Duyn, PhD No disclosure on file
Ying-Fa Chen, MD No disclosure on file
Jia S. Liu, MD No disclosure on file
John Kerrigan III, MD No disclosure on file
Mary Reilly, MD, FRCP, FRCPI The institution of Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alynlam. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AKCEA. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inflectis. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MRC. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from NIH. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MDA.
James Otis, MD, FAAN Dr. Otis has nothing to disclose.
John Betjemann, MD No disclosure on file
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Richard Abresch No disclosure on file
Mohammad A. Al-Muhaizea, MD Dr. Al-Muhaizea has nothing to disclose.
Dina R. Amrom, MD No disclosure on file
Shmuel Appel No disclosure on file
Omer Bar-Yosef, MD No disclosure on file
Sat Dev Batish, PhD, FAAN Dr. Batish has received stock or an ownership interest from Quest Diagnostics.
Peter Bede, MD, PhD Dr. Bede has nothing to disclose.
Gary W. Beecham, PhD The institution of Dr. Beecham has received research support from NIH. The institution of an immediate family member of Dr. Beecham has received research support from NIH.
Saeed A. Bohlega, MD No disclosure on file
Jean-Martin Boulanger, MD, FRCPC No disclosure on file
Ellen Carl, MS No disclosure on file
Jojy V. Cheriyan, MD No disclosure on file
Patrick F. Chinnery, MRCP No disclosure on file
Jeffrey M. Dayno, MD Dr. Dayno has received personal compensation for serving as an employee of Harmony Biosciences. Dr. Dayno has received stock or an ownership interest from Harmony Biosciences.
Leonardo De Souza No disclosure on file
Nomazulu Dlamini, MD, PhD, MSc No disclosure on file
Elizabeth Donner, MD, FRCPC Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Donner has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seizure. The institution of Dr. Donner has received research support from SickKids Centre for Brain and Mental Health. The institution of Dr. Donner has received research support from Ontario Brain Institute. The institution of Dr. Donner has received research support from CIHR.
Alan Evans, PhD Dr. Evans has received personal compensation for serving as an employee of biospective. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for biospective.
Faisal Fecto, MD, PhD The institution of Dr. Fecto has received research support from NINDS.
Giovanni B. Frisoni, MD No disclosure on file
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Anne K. Grunewald, PhD No disclosure on file
Andrea L. Gropman, MD, FAAN Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor Mirica. Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Immedica. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health.
Angela Hardwick, MD No disclosure on file
Daniel M. Harrison, MD, FAAN Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American College of Physicians. The institution of Dr. Harrison has received research support from Roche-Genentech. Dr. Harrison has received publishing royalties from a publication relating to health care.
Eric V. Hastriter, MD No disclosure on file
Ismail A. Khatri, MD, MBBS, FAAN Dr. Khatri has nothing to disclose.
Kathryn F. Kirchoff, MD Dr. Kirchoff has nothing to disclose.
Victor Laluz No disclosure on file
Giulia Longoni, MD Dr. Longoni has nothing to disclose.
Christopher Magnano No disclosure on file
Facundo Manes No disclosure on file
Celedonio Marquez, MD No disclosure on file
Berge A. Minassian, MD Dr. Minassian has nothing to disclose.
Yoshiko Nomura, MD, PhD No disclosure on file
Fabiana Ortega No disclosure on file
Fernando L. Pagan, MD, FAAN Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Eun Kyung Park, MD No disclosure on file
Jennifer Pettiford No disclosure on file
Simona Pontecorvo No disclosure on file
Pierre-Marie Preux, MD No disclosure on file
Andrew Protter No disclosure on file
Luc J. Regal, MD No disclosure on file
Sindhu Ramchandren, MD Dr. Ramchandren has received personal compensation for serving as an employee of Janssen Pharmaceutical Companies of Johnson & Johnson.
Alberto Ramos, MD, FAAN Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for One Care Media, LLC. Dr. Ramos has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Heart, Lung and Blood Institute . The institution of Dr. Ramos has received research support from Axsome pharmaceutical. The institution of Dr. Ramos has received research support from NIH. The institution of Dr. Ramos has received research support from National Institutes of Aging/NIH. Dr. Ramos has received personal compensation in the range of $500-$4,999 for serving as a Clinical Advisor with Neurogeneces, Inc. Dr. Ramos has a non-compensated relationship as a Editorial Board with Chest Scientific Journal that is relevant to AAN interests or activities.
Anmar Razak, MD Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Gregory A. Rippon, MD, FAAN Dr. Rippon has received personal compensation for serving as an employee of Genentech. Dr. Rippon has stock in Genentech.
Jack C. Rose, MD No disclosure on file
Monica Sapo No disclosure on file
Reinhold Schmidt, MD No disclosure on file
Claudiu Schirda, PhD Dr. Schirda has nothing to disclose.
Michael Schroeter No disclosure on file
Jisoo S. Shin, MD No disclosure on file
Michael A. Slifer No disclosure on file
Sachin Talathi No disclosure on file
Delia M. Talos, MD No disclosure on file
David Tanne, MD No disclosure on file
Robert J. Thomas, MD Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Councils. Dr. Thomas has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Thomas has received intellectual property interests from a discovery or technology relating to health care. Dr. Thomas has received publishing royalties from a publication relating to health care.
Thanh Ton, PhD No disclosure on file
Ayesha N. Vohra, MD No disclosure on file
Cui Yang, MD No disclosure on file
Hye R. Yang, MD No disclosure on file
Dileep R. Yavagal, MD, FAAN Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Patrick Yu-Wai-Man Patrick Yu-Wai-Man has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight Biologics. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Chiesi. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Patrick Yu-Wai-Man has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PYC Therapeutics.
Nassim Zecavati, MD, FAAN Dr. Zecavati has nothing to disclose.
Carmen Paradas Lopez, MD, PhD No disclosure on file
Horacio Senties Madrid No disclosure on file
Andrew R. Spector, MD, FAAN Dr. Spector has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Noctrix. Dr. Spector has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. Dr. Spector has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Spector has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology: Clinical Practice. Dr. Spector has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Shevlin Smith. Dr. Spector has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Armstrong Teasdale. The institution of an immediate family member of Dr. Spector has received research support from NIH/NIAID. The institution of an immediate family member of Dr. Spector has received research support from AAAAI Foundation. The institution of an immediate family member of Dr. Spector has received research support from Thurston Arthritis Research Center at UNC. Dr. Spector has received publishing royalties from a publication relating to health care.
Roy G. Beran, MD, FAAN Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esai. Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for somnomed. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CMC Lawyers. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bannisters Lawyers. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Victorian Crown prosecution. Dr. Beran has received publishing royalties from a publication relating to health care. Dr. Beran has received publishing royalties from a publication relating to health care.
Jason Doescher, MD No disclosure on file
El-Hadi Mouderres, MD No disclosure on file
Vikas Gupta, MD Dr. Gupta has nothing to disclose.
Haythum O. Tayeb, MD Dr. Tayeb has nothing to disclose.
Shafiuddin Ahmed, MD No disclosure on file
Constantine Farmakidis, MD, FAAN Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for J&J. Dr. Farmakidis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Muscular Dystrophy Association.
Benjamin L. Walter, MD Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott.
Eugene Major, PhD No disclosure on file
Kevin E. Chapman, MD No disclosure on file
Genevieve Legault, MD No disclosure on file
Benjamin Hui, MD No disclosure on file
Samiah A. Al-Zaidy, MD Dr. Al-Zaidy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AveXis Inc.
Vida Abedi No disclosure on file
Daniel C. Adusei No disclosure on file
Farzad Moien Afshari, MD No disclosure on file
Sachin Agarwal, MD, MPH Dr. Agarwal has nothing to disclose.
Hamed Akhlaghi, MD No disclosure on file
Balint Alkonyi, MD No disclosure on file
Ahood M. Almuslamani No disclosure on file
Luiz A. Andrade, MD, PhD No disclosure on file
William T. Andrews, MD No disclosure on file
Deepak Arjundas, MD No disclosure on file
Elissa L. Ash, MD, PhD Dr. Ash has nothing to disclose.
Asimina Athanasouli Asimina Athanasouli has nothing to disclose.
Guney Bademci No disclosure on file
Lindsay Barker, PhD No disclosure on file
Hector Barragan No disclosure on file
Orlando G. Barsottini, MD, PhD Dr. Barsottini has nothing to disclose.
Hassaan H. Bashir, MBBS No disclosure on file
Nerses Bebek, MD, PhD Dr. Bebek has nothing to disclose.
Felix Benninger, MD Dr. Benninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurohelp.
Beverly Benson, PhD No disclosure on file
Sushanth Bhat, MD Dr. Bhat has nothing to disclose.
Pallab K. Bhattacharyya, PhD Dr. Bhattacharyya has nothing to disclose.
Nezha Birouk No disclosure on file
Helene Blasco, PhD No disclosure on file
Marina Boccardi, PhD No disclosure on file
Sylvia Boesch, MD Dr. Boesch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VICO. Dr. Boesch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for REATA.
Vanderci Borges No disclosure on file
Leorah Freeman, MD No disclosure on file
Abderrahim Bougteba No disclosure on file
Riley Bove, MD, FAAN Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.
Dreama V. Brar, MD No disclosure on file
Stefan Braune Stefan Braune has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTransData. Stefan Braune has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Stefan Braune has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for NeuroTransData.
Vesna V. Brinar, MD, PhD No disclosure on file
Jeremy D. Burgess No disclosure on file
David B. Burkholder, MD, FAAN The institution of Dr. Burkholder has received research support from Longboard pharmaceuticals.
Joshua Burns, PhD No disclosure on file
Gianna Casini No disclosure on file
Fernando Castellanos, MD No disclosure on file
Veronica Castillo, PhD No disclosure on file
Tatiana Cattaruzza, MD No disclosure on file
Jang-Ho J. Cha, MD, PhD No disclosure on file
Abhijit Chaudhuri No disclosure on file
Christian D. Chavarro-Nieto, MD No disclosure on file
Christina Cheung, MD No disclosure on file
Hsin F. Chien, MD, PhD No disclosure on file
Florence Chukwuneke, RN No disclosure on file
John Conklin No disclosure on file
Dennis J. Cordato, MBBS, PhD, FRACP No disclosure on file
Shelagh Coutts, MD No disclosure on file
David R. Curfman, MD Dr. Curfman has nothing to disclose.
Mona Darwish, PhD Dr. Darwish has nothing to disclose.
Subasini Dash, MD No disclosure on file
Maarten de Rijk, MD No disclosure on file
John DeCerce, MD No disclosure on file
Nicholas Deconinck Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Nicholas Deconinck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Nicholas Deconinck has received publishing royalties from a publication relating to health care.
Elisa Delloglio, MD No disclosure on file
Sushrut Dharmadhikari, MD Dr. Dharmadhikari has nothing to disclose.
Ian Donaldson, MBBS No disclosure on file
Shelly Miller No disclosure on file
Simon Duchesne, PhD Dr. Duchesne has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Qynapse SAS. Dr. Duchesne has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Group. Dr. Duchesne has received stock or an ownership interest from Qynapse SAS. Dr. Duchesne has received intellectual property interests from a discovery or technology relating to health care.
Stephen P. Duntley, MD No disclosure on file
Daniel Elefant No disclosure on file
Timothy M. Ellmore, PhD Prof. Ellmore has nothing to disclose.
Francesco Federico No disclosure on file
Andre C. Felicio No disclosure on file
Henrique B. Ferraz, MD Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for FQM. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Zambon. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Dr. Ferraz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Ipsen.
Ekokobe Fonkem, DO Dr. Fonkem has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Fonkem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Fonkem has stock in Global Cancer Technology.
Joanna J. Gan, MD No disclosure on file
Brian Gerhardstein, MD, PhD No disclosure on file
Allan M. Glanzman, PT Mr. Glanzman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Mr. Glanzman has received intellectual property interests from a discovery or technology relating to health care.
Daniel Goldberg-Zimring, PhD No disclosure on file
Marina C. Gonsales No disclosure on file
Neil C. Griffith, MD, FRACP No disclosure on file
Harald Hampel Harald Hampel has received personal compensation for serving as an employee of Eisai Inc..
Simon Hawke No disclosure on file
Edward Hellriegel No disclosure on file
Frederick Holdbrook Frederick Holdbrook has received personal compensation for serving as an employee of Amicus Therapeutics, Inc. Frederick Holdbrook has stock in Amicus Therapeutics, Inc.
Dongya Huang, MD No disclosure on file
Parameswaran M. Iyer, Jr., MD, MBBS No disclosure on file
Israt Jahan, MD No disclosure on file
Neena Jamwal, MD Dr. Jamwal has nothing to disclose.
Ruchira M. Jha, MD Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. An immediate family member of Dr. Jha has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal fees. The institution of Dr. Jha has received research support from NIH/NINDS, Chuck Noll Foundation, University of Pittsburgh, Barrow Neurological Foundation.
Yo-El Ju, MD The institution of Dr. Ju has received research support from National Institutes of Health.
Csaba Juhasz, MD The institution of Dr. Juhasz has received research support from NIH.
Nadja Kadom No disclosure on file
Aisha Khaleeq No disclosure on file
Mausumi Lidogoster, MD No disclosure on file
Mary Kirby, MD No disclosure on file
Joshua P. Klein, MD, PhD, FANA, FAAN Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Norman Kock, MD No disclosure on file
Suleiman Kojan, MD, FAAN No disclosure on file
Darcy Krueger, MD Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NobelPharma USA. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for RegenxBio. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis Pharmaceuticals. Dr. Krueger has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Greenwich Biosciences. The institution of Dr. Krueger has received research support from Greenwich Bioscience. The institution of Dr. Krueger has received research support from Marinus Pharmaceuticals. The institution of Dr. Krueger has received research support from National Institutes of Health. The institution of Dr. Krueger has received research support from Food and Drug Administration. The institution of Dr. Krueger has received research support from TSC Alliance.
Rajeev Kumar, MD, MBBS No disclosure on file
Oh Dae Kwon No disclosure on file
Min-Yu Lan No disclosure on file
Tobias Langheinrich, MD No disclosure on file
Eric Le Guern No disclosure on file
Maria Liguori, MD, PhD No disclosure on file
Camila G. Lopes, MD No disclosure on file
Penny MacDonald, MD PhD No disclosure on file
Rama K. Maganti, MD, FAAN No disclosure on file
Gian Michele Malentacchi No disclosure on file
Soe S. Mar, MD, FAAN The institution of Dr. Mar has received research support from NIH.
David A. Marks, MD Dr. Marks has nothing to disclose.
Jose F. Marti Masso, MD No disclosure on file
Laura Mason, MD No disclosure on file
Genevieve Matte, MD Dr. Matte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Matte has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amylyx. Dr. Matte has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for mitsubishi tanabe pharma canada. Dr. Matte has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for alnylam. Dr. Matte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for amylyx. Dr. Matte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for mitsubishi tanabe pharma canada. Dr. Matte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for alnylam. Dr. Matte has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for csl behring. The institution of Dr. Matte has received research support from mitsubishi tanabe pharma. The institution of Dr. Matte has received research support from cytokinetics. The institution of Dr. Matte has received research support from annexon. The institution of Dr. Matte has received research support from calico. The institution of Dr. Matte has received research support from QurAlis.
Alan J. McDougall, PhD, FRACP No disclosure on file
Roger McKelvey, MD No disclosure on file
Rafael Medina-Flores, MD No disclosure on file
Sonal Mehta, MD Dr. Mehta has nothing to disclose.
Helena Rezende S. Mendonca, PhD No disclosure on file
Erica Menegatti, PhD No disclosure on file
Jhanvi Menon, MD No disclosure on file
Michael Tymianski, MD, PhD, FRCSC Michael Tymianski, MD, PHD, FRCSC has received personal compensation for serving as an employee of NoNO Inc.. Michael Tymianski, MD, PHD, FRCSC has stock in NoNO Inc.
Alberto Mimenza, MD No disclosure on file
Michael Mlynash No disclosure on file
Henry P. Moore, MD Dr. Moore has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Moore has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen Pharma. The institution of Dr. Moore has received research support from Sage Therapeutics. The institution of Dr. Moore has received research support from Bukwang Pharmaceutical. The institution of Dr. Moore has received research support from Neurocrine. The institution of Dr. Moore has received research support from CDHI Foundation. The institution of Dr. Moore has received research support from MODUS Outcomes LLC. The institution of Dr. Moore has received research support from University of Kansas Center for Research.
Mohammad Moussavi, MD Dr. Moussavi has nothing to disclose.
Francesco Muntoni, MD Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sarepta. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Muntoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Muntoni has received research support from European Commission. The institution of Dr. Muntoni has received research support from Medical Research Council. The institution of Dr. Muntoni has received research support from Biogen. The institution of Dr. Muntoni has received research support from Muscular Dystrophy UK. The institution of Dr. Muntoni has received research support from MDA USA. The institution of Dr. Muntoni has received research support from Sarepta. The institution of Dr. Muntoni has received research support from Association Francoise Myopathies. Dr. Muntoni has received personal compensation in the range of $0-$499 for serving as a Clinical expert with UK NICE Committee.
Lauren Mylacraine No disclosure on file
Emily Nakagawa, DO No disclosure on file
Jelena D. Nikodinovic Glumac, MD No disclosure on file
Brian Owens No disclosure on file
Remia Paduga, MD Dr. Paduga has nothing to disclose.
Coro Paisan Ruiz No disclosure on file
Zsuzsanna Pal No disclosure on file
Otto Pedraza The institution of Otto Pedraza has received research support from Alzheimer's Association. Otto Pedraza has received publishing royalties from a publication relating to health care.
Joelle Proulx-Therrien No disclosure on file
Adriana Prundean, MD No disclosure on file
Michael T. Pulley, MD, PhD, FAAN Dr. Pulley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for amylyx. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for csl/behring. Dr. Pulley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Pulley has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Multiple law firms.
Janice M. Redmond, MD Dr. Redmond has nothing to disclose.
Kenneth Rice No disclosure on file
Sharon Richardson, MD No disclosure on file
Mario Riverol, MD No disclosure on file
Tyler Rolheiser No disclosure on file
Victor W. Rosenfeld, MD No disclosure on file
Francesca Rossi, PhD No disclosure on file
Patricia Sacco, MPH No disclosure on file
Peter Sazani, PhD No disclosure on file
Fabien Scalzo, PhD Prof. Scalzo has nothing to disclose.
Kerrie Schoffer, MD No disclosure on file
Daniel R. Scoles, PhD, FAAN The institution of Dr. Scoles has received research support from NIH.
Patricia D. Scripko, MD No disclosure on file
Tricia See, ScM No disclosure on file
Madeleine Sharp, MD No disclosure on file
Monica A. Skordilis, MD No disclosure on file
Irving Smith, DO No disclosure on file
Hilkka S. Soininen, MD, PhD Dr. Soininen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk.
Elizabeth Soto Cabrera, MD No disclosure on file
Tess Fitzpatrick, MD No disclosure on file
Namratha Sudharshan, MD No disclosure on file
Suzanne J. Hodgkinson, MD, MBBS, PhD, FRACP The institution of Dr. Hodgkinson has received research support from MERCK. The institution of Dr. Hodgkinson has received research support from Atara. The institution of Dr. Hodgkinson has received research support from Biogen . The institution of Dr. Hodgkinson has received research support from Genzyme. The institution of Dr. Hodgkinson has received research support from ROCHE. The institution of Dr. Hodgkinson has received research support from Novartis.
Shahamat Tauhid, MD Dr. Tauhid has nothing to disclose.
Matthew Tenser, MD No disclosure on file
Andrea Tettamanti No disclosure on file
Avner Thaler, MD The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Stephen Thein, PhD No disclosure on file
Tommy T. Thomas, MD, PhD Dr. Thomas has nothing to disclose.
Ka Ka Ting, PhD No disclosure on file
Win Toe, MD No disclosure on file
Thomas Tsolis No disclosure on file
Wim Van Hecke, PhD Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
Edwin S. Vargas, MD Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Vargas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for CSL Berhing.
Louis Verret, MD No disclosure on file
Lisa Voges No disclosure on file
Sarah Wahlster, MD Dr. Wahlster has nothing to disclose.
Simon Warfield No disclosure on file
Daniel Weisholtz, MD No disclosure on file
Shelly K. Weiss, MD No disclosure on file
Katherine Wong, MD Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various law firms. Dr. Wong has stock in Biogen.
Tao Xie, MD Dr. Xie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CVS/Caremark. Dr. Xie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharmaceutical Ltd. Dr. Xie has received research support from NIH.
Mohamed Yahyaoui No disclosure on file
Ramin Zand, MD Dr. Zand has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for StrokeExperts. The institution of Dr. Zand has received research support from NIH. The institution of Dr. Zand has received research support from PCORI.
Jingwu Zhang, MD, PhD No disclosure on file
Yi-Cheng Zhu, MD, PhD Dr. Zhu has nothing to disclose.
Julie Turnbull No disclosure on file
Salah E. Omer, FRCP No disclosure on file
Kenneth Gross, MD No disclosure on file
Michael Schrift, DO No disclosure on file
Augusto Morales, MD No disclosure on file
Toby I. Gropen, MD Dr. Gropen has nothing to disclose.
Sarah Janicki, MD No disclosure on file
Amrou Sarraj, MD Dr. Sarraj has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker Neurovascular. Dr. Sarraj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker Neurovascular. The institution of Dr. Sarraj has received research support from Stryker Neurovascular.
Eoin P. Flanagan, MBBCh, FAAN The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
Divisha Raheja, MD, FAAN Dr. Raheja has nothing to disclose.
Shruti P. Agnihotri, MD An immediate family member of Dr. Agnihotri has stock in Pfizer. The institution of Dr. Agnihotri has received research support from Roche/ Genentech.
Leslie A. Benson, MD The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program.
Ashkan Mowla, MD, FAAN No disclosure on file
Pavan Bhargava, MD, FAAN The institution of Dr. Bhargava has received research support from EMD Serono. The institution of Dr. Bhargava has received research support from Amylyx pharmaceuticals. The institution of Dr. Bhargava has received research support from Genentech. The institution of Dr. Bhargava has received research support from GSK.
Hans H. Shuhaiber, MD The institution of Dr. Shuhaiber has received research support from SPRINGWORKS . The institution of Dr. Shuhaiber has received research support from RECURSION . The institution of Dr. Shuhaiber has received research support from AstraZeneca. The institution of Dr. Shuhaiber has received research support from CTF. The institution of Dr. Shuhaiber has received research support from NFLECTION .
Julieta E. Arena, MD Dr. Arena has nothing to disclose.
Koldo Berganzo Corrales, MD No disclosure on file
Massimiliano Copetti No disclosure on file
Rachel P. Guimaraes, PT Ms. Guimaraes has nothing to disclose.
Luiza G. Piovesana, MD No disclosure on file
Melih Tutuncu, MD No disclosure on file
Adam De Havenon, MD, FAAN Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Jennifer Simpson, MD Dr. Simpson has nothing to disclose.
Navid Seraji-Bozorgzad, MD No disclosure on file
Sanjeeva R. Onteddu, MD, FAAN Dr. Onteddu has nothing to disclose.
Nicolas A. Bianchi, MD Dr. Bianchi has received personal compensation in the range of $0-$499 for serving as a Consultant for Innovation Hub Enterprises, LLC. The institution of Dr. Bianchi has received research support from Emory Medical Care Foundation.
Adam Kelly, MD, FAAN Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grand Rounds/Included Health. Dr. Kelly has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. Dr. Kelly has received personal compensation in the range of $500-$4,999 for serving as a Question writer for various educational offerings with 好色先生.
Anand V. Patel, MD Dr. Patel has nothing to disclose.
Tyson Burghardt, MD No disclosure on file
Claude Nguyen, MD Dr. Nguyen has nothing to disclose.
Mitchell M. Danesh, MD Dr. Danesh has nothing to disclose.
Marko Petrovic, MD Dr. Petrovic has nothing to disclose.
Sammy D. Pishanidar, MD No disclosure on file
Andre P. Matta, MD Dr. Matta has received personal compensation for serving as an employee of Sanofi. Dr. Matta has received stock or an ownership interest from Sanofi.
Fiona M. Baumer, MD Dr. Baumer has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Curtis & Co. Dr. Baumer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cades Schutte LLP. An immediate family member of Dr. Baumer has stock in Apple (Apple Watch is wearable). An immediate family member of Dr. Baumer has stock in Google (owns Fitbit). The institution of Dr. Baumer has received research support from NINDS. The institution of Dr. Baumer has received research support from Doris Duke/Rita Allen Foundation. The institution of Dr. Baumer has received research support from Pediatric Epilepsy Research Foundation. The institution of Dr. Baumer has received research support from Stanford University. Dr. Baumer has received personal compensation in the range of $0-$499 for serving as a Presenter; honorarium with AES. Dr. Baumer has received personal compensation in the range of $0-$499 for serving as a Presenter; honorarium with ACNS. Dr. Baumer has received personal compensation in the range of $0-$499 for serving as a Teacher at TMS-EEG Science Course; honorarium with Aalto University (Finland).
Jared Cook No disclosure on file
Manoj K. Sammi, PhD Dr. Sammi has received research support from Race to Erase MS. Dr. Sammi has received research support from Myelin Repair Foundation. Dr. Sammi has received research support from Revalesio. Dr. Sammi has received research support from Paul G. Allen Family Foundation. Dr. Sammi has received research support from Conrad F Hilton Foundation Innovation Fund. Dr. Sammi has received research support from NIH/NIDDK.
Sergio Lindembaum No disclosure on file
Virgilio D. Salanga, MD, FAAN No disclosure on file
Arnold J. Sansevere, MD Dr. Sansevere has nothing to disclose.
Samuel A. Ellias, MD, PhD No disclosure on file
Alan Wang, MD, FAAN Dr. Wang has stock in AbbVie.
Siddhart K. Mehta, MD Dr. Mehta has nothing to disclose.
James T. Houston, MD No disclosure on file
Omar Ahmad, MD No disclosure on file
Seref Demirkaya, PhD No disclosure on file
Omran Kaskar, MD No disclosure on file
Neha Mirchandani, MD No disclosure on file
Clara Chisari, MD Clara Chisari, MD has nothing to disclose.
Muriel Stoppe Muriel Stoppe has nothing to disclose.
Janace Hart No disclosure on file
Hossam A. Shaltout, PhD Dr. Shaltout has nothing to disclose.
Nirubol Tosakulwong Nirubol Tosakulwong has nothing to disclose.
Farhaan S. Vahidy, MBBS, PhD Dr. Vahidy has nothing to disclose.
Brion D. Reichler, MD No disclosure on file
Nancy E. Bass, MD Dr. Bass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseviert.
Fermina A. Pirmohamed, MD No disclosure on file
Christelle M. Achkar, MD Dr. Achkar has nothing to disclose.
Thomas V. Kodankandath, MD, FAAN Dr. Kodankandath has nothing to disclose.
Cynthia Bonilha Da Silva, MD No disclosure on file
Julia Pakpoor, MBBS No disclosure on file
Zabeen K. Mahuwala, MD, FAAN Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for academic CME. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Scientific affairs. Dr. Mahuwala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for amgen. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Anya Turetsky, MD No disclosure on file
John Hanna, MD No disclosure on file
Jasper Chen, MD, MPH No disclosure on file
Caroline B. Braune, MD Dr. Braune has nothing to disclose.
Elizabeth M. Monohan, MD Dr. Monohan has nothing to disclose.
Kim Yen Thi Vu, LMSW No disclosure on file
Rosamma Joseph, MD Dr. Joseph has nothing to disclose.
Richard Libman, MD, FAAN Dr. Libman has nothing to disclose.
Merredith R. Lowe, MD No disclosure on file
Charles Tilbery, MD No disclosure on file
Karameh Hawash Kuemmerle, MD No disclosure on file
Lawrence W. Ver Hoef, MD Dr. Ver Hoef has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bowling & Christiansen. The institution of Dr. Ver Hoef has received research support from NIH. The institution of Dr. Ver Hoef has received research support from AES.
Benjamin Turner, MD, MBBS No disclosure on file
Thomas S. Wingo, MD Dr. Wingo has nothing to disclose.
Amy L. Jones, MD No disclosure on file
Kester Phillips, MD No disclosure on file
Danny R. Rose, Jr., MD No disclosure on file
Stacey L. Hughes No disclosure on file
Elizabeth C. Neil, MD No disclosure on file
Mark A. Callow, MD No disclosure on file
Murat Kurtuncu, MD Dr. Kurtuncu has nothing to disclose.
Zakraus K. Mahdavi, MD No disclosure on file
Arun S. Chhabra, MD Dr. Chhabra has stock in Pfizer. Dr. Chhabra has stock in Biogen. Dr. Chhabra has stock in Johnson and Johnson. Dr. Chhabra has stock in Medtronic.
John D. Eatman, MD No disclosure on file
Sam H. Horng, MD, PhD The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Satya R. Vemula, MD No disclosure on file
Audrey Thurm No disclosure on file
Mohammad Abu-Rub, MD Dr. Abu-Rub has nothing to disclose.
Jan A. Martin, MD Dr. Martin has nothing to disclose.
Awss Zidan, MD An immediate family member of Dr. Zidan has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ruham Nasany MD.
Niraja S. Suresh, MD Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anylam . Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexeion. Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenex. Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda . Dr. Suresh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer.
Payal B. Patel, MD The institution of Dr. Patel has received research support from National Institute of Health. The institution of Dr. Patel has received research support from AHRQ. Dr. Patel has received personal compensation in the range of $0-$499 for serving as a Author with MedLink Neurology.
Philip H. Montenigro Mr. Montenigro has received personal compensation for serving as an employee of Arvinas. Mr. Montenigro has received personal compensation for serving as an employee of Eli Lilly. Mr. Montenigro has received personal compensation for serving as an employee of Biogen. Mr. Montenigro has stock in Biogen. Mr. Montenigro has received intellectual property interests from a discovery or technology relating to health care.
Elizabeth H. Wise, APRN Ms. Wise has nothing to disclose.
Paula Barreras, MD Dr. Barreras has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Barreras has received research support from Foundation for Sarcoidosis Research. The institution of Dr. Barreras has received research support from 好色先生.
Vinit V. Oommen, MD No disclosure on file
Cecilia Vidal, MD No disclosure on file
Gorm Pihl-Jensen No disclosure on file
Omer Suhaib, MD, MBBS No disclosure on file
Anthony Kwan No disclosure on file
Pedro Sudbrack Oliveira, MD No disclosure on file
Leslie R. Blackshear No disclosure on file
Aisha M. Ali, MD Dr. Ali has nothing to disclose.
Freddy Alfaro-Martinez, MD No disclosure on file
Sujan Teegala S. Reddy, MD Dr. Reddy has nothing to disclose.
Gerald banks No disclosure on file
Jesse Dawson Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boeringher Ingelheim. Jesse Dawson, 12284 has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic.
Achint A. Patel No disclosure on file
John D. Medaglia, PhD The institution of Dr. Medaglia has received research support from National Institutes of Health.
James Im, MD Dr. Im has nothing to disclose.
Karl O. Boyle, MD No disclosure on file
Charles D. Schutt, MD Dr. Schutt has nothing to disclose.
Venugopalan Y. Vishnu, MD The institution of Dr. Vishnu has received research support from Department of Health Research.
Rebekah Mannix, MD, MPH No disclosure on file
Kylie Ternes, MD No disclosure on file
Tamara Opila No disclosure on file
Paul Wright, MD, FAAN Dr. Wright has nothing to disclose.
Carmen Alonso No disclosure on file
Michal Vytopil, MD Dr. Vytopil has nothing to disclose.
Patricia L. Cairola, MBBS No disclosure on file
Behrang Saminejad, MD Dr. Saminejad has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus pharmacutical . Dr. Saminejad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Saminejad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine . Dr. Saminejad has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus.
Christopher J. Deline, MD No disclosure on file
Brian Marcus, MD No disclosure on file
Sierra C. Ford, DO No disclosure on file
Romanus R. Faigle, MD, PhD Dr. Faigle has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for several law firms. The institution of Dr. Faigle has received research support from The Morninstar Foundation.
Babak Razavi, MD, PhD Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Jennifer Padilla Martinez, MD No disclosure on file
Christopher B. Lening, MD No disclosure on file
Benjamin A. Jones, MD Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a expert reviewer with Vaccine Injury Compensation Program.
Jaskiran Brar, MD No disclosure on file
Steven O'Donnell, MD No disclosure on file
Harina K. Chahal, MD No disclosure on file
Joshua N. Daniel, MD No disclosure on file
Ankush Bhatia, MD No disclosure on file
Jennifer L. Jaskiewicz, DO No disclosure on file
Pradeep N. Selvan, MD No disclosure on file
Nandini R. Kumar No disclosure on file
Antonella Veneziano No disclosure on file
Dareen AlShaer, MD No disclosure on file
Alaa F. Khayat, MBBS No disclosure on file
Prachaya Srivanitchapoom, MD No disclosure on file
David Cantu, PhD Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Antonio Belenguer Benavides No disclosure on file
Raquel Custodio Da Silveira, MD No disclosure on file
John Ko, PharmD, MS Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Candice Chapouly, PhD, PharmD No disclosure on file
Omar Al-Louzi, MD The institution of Dr. Al-Louzi has received research support from the National Multiple Sclerosis Society and American Brain Foundation. The institution of Dr. Al-Louzi has received research support from the Department of Defense.
John Maeglin Mr. Maeglin has nothing to disclose.
Daniel Korya, MD No disclosure on file
Navaz Karanjia, MD Dr. Karanjia has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Kenneth Sigelman, LLC. Dr. Karanjia has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Norris & Keplinger, LLC.
Daniela M. Khouri, Jr., MD Dr. Khouri has nothing to disclose.
Maija Swanson No disclosure on file
Connor Hawkins No disclosure on file
Katie Lehman No disclosure on file
Milton Biagioni, MD No disclosure on file
Chava A. Creque No disclosure on file
Mariana F. Xavier, MD No disclosure on file
Katherine A. Heller, PhD No disclosure on file
Lena Josephs, BA No disclosure on file
Sara Mason No disclosure on file
Jan Mosion No disclosure on file
Vimal Patel No disclosure on file
Harshil Shah, Jr., MBBS No disclosure on file
Gordon Sze Gordon Sze has nothing to disclose.
Serena Yin, MD Dr. Yin has nothing to disclose.